<SEC-DOCUMENT>0001213900-20-011300.txt : 20200507
<SEC-HEADER>0001213900-20-011300.hdr.sgml : 20200507
<ACCEPTANCE-DATETIME>20200507162857
ACCESSION NUMBER:		0001213900-20-011300
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200507
DATE AS OF CHANGE:		20200507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SG BLOCKS, INC.
		CENTRAL INDEX KEY:			0001023994
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
		IRS NUMBER:				954463937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-237682
		FILM NUMBER:		20856916

	BUSINESS ADDRESS:	
		STREET 1:		195 MONTAGUE STREET, 14TH FLOOR
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11201
		BUSINESS PHONE:		(646) 240-4235

	MAIL ADDRESS:	
		STREET 1:		195 MONTAGUE STREET, 14TH FLOOR
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CDSI HOLDINGS INC
		DATE OF NAME CHANGE:	19990114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PC411 INC
		DATE OF NAME CHANGE:	19961001
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>ea121496-424b4_sgblocks.htm
<DESCRIPTION>PROSPECTUS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Pursuant to Rule 424(b)(4)</B></FONT></TD></TR>
<TR STYLE="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration No.
    333-237682</B></FONT></TD></TR>
</TABLE>

<P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6,000,000
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="img_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SG
Blocks, Inc.</B></FONT></P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are offering 6,000,000 shares of our common stock in this offering at a price of $2.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;SGBX.&rdquo; On May 6, 2020, the last reported sale
price of our common stock on the Nasdaq Capital Market was $3.30 per share. <FONT STYLE="background-color: white">The public offering
price per share of our common stock was determined between us, the underwriter and investors based on market conditions at the
time of pricing and was at a discount to the current market price of our common stock.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investing
in our securities involves risk. See &ldquo;Risk Factors&rdquo; beginning on page 8 of this prospectus for a discussion of information
that should be considered in connection with an investment in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Neither
the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities
or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per&nbsp;Share</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt">Public offering price</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2.50</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">15,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts and commissions <SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.175</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,050,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Net proceeds to us (before expenses)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2.325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">13,950,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The underwriters
    will receive compensation in addition to the discounts and commissions. The registration statement, of which this prospectus
    is a part, also registers for sale warrants to purchase 300,000&nbsp;shares of our common stock to be issued to the representative
    of the underwriters. We have agreed to issue the warrants to the representative of the underwriters as a portion of the underwriting
    compensation payable to the underwriters in connection with this offering. See &ldquo;Underwriting&rdquo; for a description
    of compensation payable to the underwriters. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
have granted a 45-day option to the representative of the underwriters to purchase up to 900,000 additional shares of common stock
from us solely to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriter expects to deliver the shares of our common stock against payment therefor on or about May 11, 2020, subject to
customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ThinkEquity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>a
division of Fordham Financial Management, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
date of this prospectus is May 6, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="img_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-right: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; width: 90%; border-bottom: black 1.5pt solid; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; width: 9%; border-bottom: black 1.5pt solid; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL NOTE REGARDING
    FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKET FOR COMMON
    EQUITY AND RELATED STOCKHOLDER MATTERS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND POLICY</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF OUR
    SECURITIES</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES
    WE ARE OFFERING</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE TO INVESTORS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND
    ADDITIONAL INFORMATION</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: top; padding-right: 0"><A HREF="#a_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF
    CERTAIN DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You
should rely only on the information contained in this prospectus and any free writing prospectus that we have authorized for use
in connection with this offering. Neither we nor the underwriters have authorized anyone to provide you with information that
is different. We are offering to sell, and seeking offers to buy, the securities covered hereby only in jurisdictions where offers
and sales are permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of
the time of delivery of this prospectus or any sale of the securities covered hereby. Our business, financial condition, results
of operations and prospects may have changed since that date. We are not, and the underwriters are not, making an offer of these
securities in any jurisdiction where the offer is not permitted. You should also read and consider the information in the documents
to which we have referred you under the caption &ldquo;Where You Can Find Additional Information&rdquo; and &ldquo;Incorporation
of Certain Documents by Reference&rdquo; in the prospectus. In addition, this prospectus contains summaries of certain provisions
contained in some of the documents described herein, but reference is made to the actual documents for complete information. All
of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have
been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus
is a part, and you may obtain copies of those documents as described below under the heading &ldquo;Where You Can Find Additional
Information.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>For
investors outside the United States: Neither we nor any of the underwriters have taken any action that would permit this offering
or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in
the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of the securities covered hereby and the distribution of this prospectus
outside of the United States.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>This
prospectus includes statistical and other industry and market data that we obtained from industry publications and research, surveys
and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate
that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or
completeness of such information. We believe that the data obtained from these industry publications and third-party research,
surveys and studies are reliable. We are ultimately responsible for all disclosure included in this prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the
registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including,
in some cases, for the purpose of allocating risk among the parties thereto, and should not be deemed to be a representation,
warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made.
Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state
of our affairs.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Except
where the context requires otherwise, in this prospectus the &ldquo;Company,&rdquo; &ldquo;SG Blocks,&rdquo; &ldquo;SGB,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to SG Blocks, Inc., a Delaware corporation formed in December 1993,
and, where appropriate, its wholly owned subsidiary, SG Building Blocks, Inc., a Delaware corporation.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_001"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>The
items in the following summary are described in more detail elsewhere in this prospectus and in the documents incorporated by
reference herein. This summary highlights selected information contained elsewhere in this prospectus. This summary is not intended
to be complete and does not contain all of the information that you should consider before deciding to invest in our securities.
You should read this entire prospectus carefully, especially the &ldquo;Risk Factors&rdquo; section beginning on page 8 and other
documents or information included or incorporated by reference in this prospectus before making an investment decision.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Company
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Using
our proprietary technology and design and engineering expertise, we modify&nbsp;code-engineered&nbsp;cargo shipping containers
and purpose-built modules for use for safe and sustainable commercial, industrial and residential building construction. Rather
than consuming new steel and lumber, our proprietary technology and design and engineering expertise allows for the redesign,
repurpose and conversion of heavy-gauge steel cargo shipping containers into SGBlocks&trade;, which are safe green building blocks
for commercial, industrial, and residential building construction. Our technology and expertise is also used to purpose-build
modules, or prefabricated steel&nbsp;modular units customized for use in modular construction (&ldquo;SGPBMs&rdquo; and, together
with SGBlocks&trade;, &ldquo;Modules&rdquo;), primarily to augment or complement an&nbsp;SGBlocks&trade;&nbsp;structure.&nbsp;Our
core customer base is comprised of architects, landowners, builders and developers who use our Modules in commercial and residential
structures. Our operating model combines product design and outsourcing of the modifications and finish out of Modules using proprietary
algorithms developed by the Company to produce and deliver Modules across the country. We believe this combination enables us
to generate economies of scale while maintaining high customer service levels in the environmentally-friendly construction space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to October 2019, our business model was solely a project-based construction model pursuant to which we were responsible for the
design and construction of finished products that incorporated our technology primarily to customers in the multi-family housing,
restaurant, military and education industries throughout the United States. In October 2019, we changed our business model for
our residential building construction to a royalty fee model when we entered into a five year exclusive license with CPF GP 2019-1
LLC (&ldquo;CPF&rdquo;) pursuant to which CPF licensed on an exclusive basis our proprietary technology, intellectual property,
any improvements thereto, and any related permits, with the right to develop and commercialize products in the United States and
its territories within the field of design and project management platforms for residential use, including, without limitation,
single-family residences and multi-family residences, but specifically excluding military housing.&nbsp;&nbsp;CPF, at the time
the License Agreement was entered into, was already a significant customer for our Modules and had completed a $5.0 million equity
financing to develop a 302-unit multifamily project in Sullivan County, New York.&nbsp; Now, in the United States with respect
to residential construction (other than residential construction for the military) we are no longer responsible for constructing
the Modules that are based on our technology or the related costs and instead that service is performed by CPF and its subcontractors
and our revenue for such residential construction is no longer generated from sales of products direct to the end customer but
instead is generated from royalties received from CPF based on the gross revenue that CPF receives from sales of products that
are based upon our technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>License
Agreement with CPF GP 2019-1 LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 3, 2019, we entered into an Exclusive License Agreement (the &ldquo;License Agreement&rdquo;) with CPF, which at the time
was one of our customers, pursuant to which we granted CPF an exclusive license (the &ldquo;License&rdquo;) solely within the
United States and its legal territories to commercialize our proprietary technology, intellectual property, any improvements thereto,
and any related permits, in order to develop and commercialize products within the field of design and project management platforms
for residential use, including, without limitation, single-family residences and multi-family residences, but specifically excluding
military housing. The Ridge Avenue Project described below has also been excluded from the License. The License Agreement has
an initial term of five (5) years and will automatically renew for subsequent five (5) year periods. The License Agreement provides
for customary termination provisions, including the right by us to terminate if CPF fails to make minimum royalty payments (as
described below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
consideration for the License, during the initial term, CPF agreed to pay us a royalty of (i) five percent (5%) on the first $20,000,000
of gross revenues derived from CPF&rsquo;s commercialization of the License (net of customary discounts, sales taxes, delivery
charges, and amounts for returns) (the &ldquo;Gross Revenues&rdquo;), (ii) four and one-half percent (4.5%) on the next $30,000,000
of Gross Revenues, and (iii) five percent (5%) on all Gross Revenues thereafter (collectively, the &ldquo;Royalty&rdquo;), subject
to the following minimum royalty payments determined on a cumulative basis during the initial term: $500,000 in year 1, $750,000
in year 2, $1,500,000 in year 3, $2,000,000 in year 4, and $2,500,000 in year 5. If the License Agreement is extended beyond the
initial term, then the parties will negotiate in good faith the royalty rate and the minimum royalty payments for the renewal
term(s). In addition, to the extent CPF sublicenses any aspect of the License to a sublicensee, CPF will pay to us fifty percent
(50%) of all payments received by CPF from such sublicensee. We may also provide CPF with professional services with respect to
the License, and CPF will reimburse us for employees&rsquo; time, materials, and expenses incurred in providing such professional
services. CPF also separately agreed to reimburse us for any third-party expenses incurred by us in developing our remaining and
future residential projects.</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
License Agreement provides for customary indemnification obligations between the parties and further provides that CPF will indemnify
us for any claims arising out of the commercialization of the License by CPF or any of its subsidiaries, contractors, or sublicensees.
In addition, the License Agreement provides that we will provide CPF with cost estimates for the fabrication and manufacturing
of residential projects in our existing pipeline as of the date of the License Agreement, and if such projects cannot be reasonably
constructed and installed at or below such estimates, then CPF may withhold payment of any royalty due to us under the License
Agreement on a dollar-for-dollar basis to offset the costs above the originally estimated amounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 3, 2019, we entered into a Loan Agreement and Promissory Note (the &ldquo;Loan Agreement&rdquo;) with CPF GP, which was
amended on October 15, 2019 and further amended on November 7, 2019 pursuant to which we agreed to loan CPF GP $750,000 at an
annual interest rate of five percent (5%), with a maturity date of July 31, 2023. Under the Loan Agreement, we advanced to CPF
GP the first installment of the principal amount, equal to $500,000, on January 31, 2020 and the second installment of the principal
amount, equal to $250,000, on April 15, 2020. As security for this loan, we received a security interest in all of CPF GP&rsquo;s
membership interests in the Licensee. If we had failed to fund either principal installment, such failure would have constituted
a default under the Loan Agreement and a cross default under the License Agreement. On January 21, 2020, pursuant to the Loan
Agreement, CPF GP issued to us a promissory note in the principal amount of $400,000 (the &ldquo;Company Note&rdquo;) and issued
to Paul Galvin, our Chairman and CEO, a promissory note in the principal amount of $100,000 (the &ldquo;Galvin Note&rdquo;). The
transaction closed on January 22, 2020, on which date we loaned CPF GP $400,000 and Mr. Galvin personally loaned CPF GP $100,000
on behalf of us. The Company Note and Galvin Note bear interest at five percent (5%) per annum, payable, together with the unpaid
principal amount of the promissory notes, on the earlier of the July 31, 2023 maturity date or upon the liquidation, redemption
sale or issuance of a dividend upon the LLC interests in CPF MF 2019-1 LLC, a Texas limited liability company of which CPF GP
is the general partner;&nbsp;provided, that the terms of the Galvin Note provide that all interest payments due to Mr. Galvin
under the Galvin Note shall be paid directly to, and for the benefit of, our Company.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The
Products Produced with Our Technology</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
building products developed with our proprietary technology and design and engineering expertise are generally stronger, more
durable, environmentally sensitive, and erected in less time than traditional construction methods. The use of the&nbsp;SGBlocks&nbsp;building
structure typically provides between&nbsp;four&nbsp;to&nbsp;six&nbsp;points towards the Leadership in Energy and Environmental
Design (&ldquo;LEED&rdquo;) certification levels, including reduced site disturbance, resource reuse, recycled content, innovation
in design and use of local and regional materials. Due to the ability of&nbsp;SGBlocks&nbsp;to satisfy such requirements, we believe
the products produced utilizing our technology and expertise is a leader in environmentally sustainable construction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are&nbsp;three&nbsp;core product offerings that utilize our technology and engineering expertise. The first product offering involves&nbsp;GreenSteel&trade;&nbsp;modules,
which are the structural core and shell of an&nbsp;SGBlocks&nbsp;building. We procure the containers, engineer required openings
with structural steel enforcements, paint the&nbsp;SGBlocks&nbsp;and then delivers them on-site, where the customer or a customer&rsquo;s
general contractor will complete the entire finish out and installation. The second product offering involves replicating the
process to create the&nbsp;GreenSteel&trade;&nbsp;product and, in addition, installing selected materials, finishes and systems
(including, but not limited to floors, windows, doors, interior painting, electrical wiring and fixtures, plumbing outlets and
bathrooms, roofing system) and delivering&nbsp;SGBlocks&nbsp;pre-fabricated containers to the site for a third party licensed
general contractor to complete the final finish out and installation. Finally, the third product offering is the completely fabricated
and finished&nbsp;SGBlocks&nbsp;building (including but not limited to floors, windows, doors, interior painting, electrical wiring
and fixtures, plumbing outlets and bathrooms, roofing systems), including erecting the final unit on site and completing any other
final steps. The building is ready for occupancy and/or use as soon as installation is completed. Construction administration
and/or project management services are typically included in our product offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ESR
Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
April 2017, the ICC Evaluation Service, LLC (&ldquo;ICC-ES&rdquo;) granted us an Evaluation Service Report (&ldquo;ESR&rdquo;)
for the SGBlocks structural building materials. We believe we are the first modular building company to receive such certification.
Our ESR indicates that the ICC-ES recognizes the suitability and technical capabilities of the SGBlocks structural building materials
for use in compliance with the International Building Code and Residential Code, the California Building Code and Residential
Code, and the Florida Building Code&mdash;Building and Residential. We believe our ESR has expedited reviews and approvals by
state and local building departments, helped the SGBlocks concept gain wider acceptance in the construction industry and opened
up licensing opportunities internationally We also believe the ESR will make it more difficult for other companies in the industry
to compete with us because the quality control and design acceptance criteria are specific to us and our associated facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
ESR is site-specific; therefore, only the inspected and approved facilities can place the ICC-ES mark on the containers. We currently
source or fabricate our SGBlocks from 18 facilities located throughout the continental United States. The ICC-ES has currently
approved six of these facilities to place the ICC-ES medallion and we will seek ICC-ES approval for additional facilities on an
as needed basis. Each of these facilities undergo an annual inspection by ICC-ES. Currently, each of these facilities has been
re-certified by ICC-ES and is current with their recertifications. All SGBlocks manufactured at these facilities have an ESR medallion
that validates the quality control process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because our ESR does not cover SGPBMs, this certification does not extend to buildings
constructed using SGPBMs.</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Target
Markets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
date, the target markets for the products that utilize our technology and expertise have been the new construction market in the
United States. The Modules that utilize our technology and expertise have a particular application in a number of segments, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Single-Family and
    Multi-Family Housing</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restaurants and
    Quick Service Restaurants</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Military</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Education/Student
    Housing</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment Enclosures
    and Stacking Solutions</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and Commercial</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hospitality and
    Entertainment</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athletic&nbsp;facilities
    and support structures</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, future target markets for expansion of such products and services include data centers, warehouse/public storage, reclamation/drop
off centers and medical.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Our
Competitive Strengths</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
the construction industry is highly competitive, we are committed to educating the real estate community on the benefits of our
technology and expertise and positioning the products that utilize our technology and expertise as complementary to the strategy
of developers, rather than as competition. We and CPF may compete for building opportunities with regional, national and international
builders that possess greater financial, marketing and other resources than we do, and competition within the general construction
industry may increase if there is future consolidation in the land development and construction industry or from new building
technologies that could arise. Within the modular building space, we compete against a small number of companies providing modular-building
services. The principal competitive factors in our business include, but are not limited to, the availability of building materials;
technical product knowledge and expertise; previous experience in modular construction; consulting or other service capabilities;
pricing of products; and the marketability of our ESR within the structural building space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe we can distinguish ourselves from our competitors on the basis of our ESR, quality, cost and construction time savings
when utilizing our technology and expertise. Our proprietary construction method is typically less expensive than traditional
construction methods, particularly in urban locations and multi-story projects, and construction time is also generally reduced
by using our construction method, reducing both construction and soft costs substantially.&nbsp;SGBlocks&nbsp;are designed to
be hurricane-, tornado- and earthquake-resistant and able to withstand harsh climate conditions. The flexibility and the stack-ability
of the Modules allows architects, developers and owners to design Modules to meet their specific needs. In addition, our management
team has a breadth of knowledge in the modular building industry with a combined&nbsp;130&nbsp;years of experience. Our experience
in a wide range of construction applications, including office, enclosures, residential, commercial, quick service restaurants,
experiential and restaurant applications, gives us an advantage over our competition through the use of market-based prototypes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Our
Customers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
and CPF market to a broad customer base, comprised primarily of contractors, home builders, building owners and other resellers
across the continental United States and we also market our services and technology to customers in Canada. At December 31, 2019
and 2018, 92% and 76%, respectively, of the Company&rsquo;s gross accounts receivable were due from one and two customers. Revenue
relating to two and&nbsp;three&nbsp;customers represented approximately 78% and 66% of the Company&rsquo;s total revenue for the
years ended December 31, 2019 and 2018, respectively.&nbsp;</FONT></P>
</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Our
Suppliers and Partners</B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
the primary use of shipping containers is for transportation, when constructing SGBlocks we use standard materials to modify the
container shell structure and finish out the modules. We utilize the same suppliers and materials used by conventional construction.
Materials such as windows, doors, insulation mechanical systems, electrical systems and other such supplies are all off-the-shelf
materials and equipment commonly available and used in the industry.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">One
of the main suppliers for our containers is ConGlobal Industries, Inc. (&ldquo;ConGlobal&rdquo;), an independent third party,
with whom we have an exclusive 10-year Collaboration and Supply Agreement (the &ldquo;ConGlobal Agreement&rdquo;) through May
14, 2024. ConGlobal is one of the largest depot operators in the United States. This arrangement provides us with a reliable source
of supply of certified shipping containers. The ConGlobal Agreement provides that ConGlobal will be our exclusive supplier of
SGBlocks for housing, office and retail uses generally constructed as permanent structures within the continental United States
within a 50 mile radius of an existing ConGlobal site and ConGlobal will not supply shipping containers modified for building
purposes to any entity competing with us during the term of the agreement. The Company believes it has access to alternative suppliers,
with limited disruption to the business, should circumstances change with its existing suppliers.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Employees</B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of May 1, 2020, we directly employed seven full-time employees and engaged outside professional firms and subcontractors to deliver
projects to customers.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Recent
Business Developments</B>&nbsp;</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
April 30, 2020, we entered into a Distributorship Agreement (the &ldquo;Distributorship Agreement&rdquo;) with Osang Healthcare
Co., Ltd., a Republic of Korea company (&ldquo;Osang&rdquo;), effective as of April 28, 2020, for its GeneFinder&trade; COVID-19
Plus RealAmp Kit&trade;, designed to detect SARS-CoV-2 (<I>Severe Acute Respiratory Syndrome-Coronavirus 2</I>), the virus that
causes COVID-19, through a gene-based reverse transcription reaction and real-time polymerase chain reaction (PCR) testing process.
The Distributorship Agreement is Osang&rsquo;s standard form of distributorship agreement and provides us with the non-exclusive
right to distribute Osang&rsquo;s GeneFinder COVID-19 Plus RealAmp Kit in the United States for a stated term of one (1) year.
Pursuant to the terms of the Distributorship Agreement, we are required to make payment for 100% of any purchase order prior to
shipment of the product from Osang, though we do not expect to make any cash outlays with respect to any product that we distribute
and expect instead to require any third-party purchasers to make the necessary cash outlays as part of a purchase order entered
into with us. The Distributorship Agreement does not guarantee us a specific quantity of kits to sell or a customer list, and
may be terminated by either party at any time on thirty (30) days&rsquo; notice. To date, we have never sold any medical devices
or kits and there can be no guarantee that we will be able to establish a sales force, establish distribution channels or solicit
customers for the kits. An import license from the U.S. government will be required to import and distribute the Osang test kits,
and we do not expect any issues in obtaining the license. There can be no assurance that the Distribution Agreement will continue,
that it will yield the anticipated benefits or generate significant revenue, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
April 30, 2020, the Distributorship Agreement was amended to provide us with certain additional warranties from Osang.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe that we have the ability to address logistical challenges concerning the distribution of these kits utilizing our modular
construction expertise, particularly our entry into the production of modular primary care medical units and COVID-19 diagnostic
testing units, as more fully described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
May 1, 2020, in connection with the entry into the Distributorship Agreement and subject to certain pre-existing participation
rights of other investors, we entered into an agreement with an affiliate of Osang granting the right to participate in up to
19.9% of any offering effected by us during the next six months, provided that Osang or its affiliates provides customer referrals
to us for the purchase under the Distributorship Agreement of kits resulting in at least $5 million of revenues to us.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
March 30, 2020, we entered into a Memorandum of Understanding with Transcend Onsite Care (&ldquo;Transcend&rdquo;), a provider
of on-site point of contact medical care, to provide joint products and services. Products that are expected to be implemented
include modular primary care medical units, COVID-19 diagnostic testing units, quarantine living units, as well as drive through
testing units at employer onsite clinics and community hospitals. The first project planned is two (2) Transcend Medical and Testing
Units to be built by us and operated by Transcend. The unit will be delivered to a major southern California employer for the
initial purposes of providing onsite COVID-19 screening through diagnostic testing and medical care for staff who are required
to work during the pandemic. The Memorandum of Understanding with Transcend does not specify a quantity of units to be built or
provide for a guarantee of services by either party. See &ldquo;Risk Factors&rdquo; below.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Recent
Financing Developments&nbsp;</B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
April 3, 2020, we completed an underwritten public offering of our common stock (the &ldquo;April 2020 Offering&rdquo;). In connection
with the April 2020 Offering, we sold&nbsp;440,000&nbsp;shares of our common stock at a public offering price of $4.25&nbsp;per
share, resulting in aggregate net proceeds of approximately $1,500,000&nbsp;after deducting underwriting discounts and commissions
and other expenses related to the April 2020 Offering.&nbsp; We intend to use the net proceeds from the April 2020 Offering primarily
for working capital and general corporate purposes, <FONT STYLE="background-color: white">funding certain contractual obligations
to CPF under the Loan Agreement pursuant to which we agreed to loan money to CPF</FONT>, and engaging in acquisitions or other
business combinations or investments, sales and marketing activities, general and administrative matters and capital expenditures.
We have not determined the amounts we plan to spend on any specific purpose or the timing of these expenditures.</FONT></P>
</DIV>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
December 13, 2019, we completed an underwritten public offering of our common stock (the &ldquo;December 2019 Offering&rdquo;).
In connection with the December 2019 Offering, we sold&nbsp;857,500&nbsp;shares of our common stock at a public offering price
of $3.00&nbsp;per share, resulting in aggregate net proceeds of $2,117,948&nbsp;after deducting underwriting discounts and commissions
and other expenses related to the December 2019 Offering.&nbsp;We incurred&nbsp;a total of $454,552&nbsp;in issuance costs in
connection with the December 2019 Offering and no warrants to purchase were issued to the underwriters. The proceeds of the December
2019 Offering were used as follows: (i) $480,770 to repay the outstanding principal amount of an outstanding debenture (the &ldquo;Debenture&rdquo;);
(ii) a portion to fund our obligation to our licensee under the terms of the Loan Agreement with CPF pursuant to which we agree
to loan CPF GP a principal amount of $750,000 at an annual interest rate of five percent (5%), with a maturity date of July 31,
2023; and (iii) the remaining net proceeds for general working capital purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>General
Corporate Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
were incorporated in the State of Delaware on December 29, 1993 under the name CDSI Holdings, Inc. On November 4, 2011, CDSI Merger
Sub, Inc., our wholly-owned subsidiary, completed a reverse merger with and into SG Building Blocks, Inc. (&ldquo;SG Building&rdquo;),
with SG Building surviving the reverse merger as our wholly owned subsidiary. We primarily conduct our current operations through
SG Building. Prior to our emergence from bankruptcy in June 2016, our common stock was quoted on the OTC Bulletin Board. In June
2017, we completed a public offering of our common stock, which currently trades on the Nasdaq Capital Market under the symbol
&ldquo;SGBX.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;SG
Blocks<SUP>TM</SUP>&rdquo;, &ldquo;GreenSteel&trade;&rdquo; and the SG logo are our trademarks. All other trademarks and service
marks appearing in this prospectus are the property of their respective owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Reverse
Stock Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.95pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
February 28, 2017, we effected a 1-for-3 reverse stock split of the common stock and preferred stock, which has since been converted
into common stock. On&nbsp;February 5, 2020, we effected a 1-for-20 reverse stock split of our common stock.</FONT></P>
</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_002"></A>The
Offering</B></FONT></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 28%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common stock offered by
    us</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 71%; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000,000
    shares of our common stock</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 2.4pt; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Public Offering Price per share of common
    stock</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2.50 per share</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 2.4pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-allotment option</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have granted
    a 45-day option to the representative of the underwriters to purchase up to 900,000 additional shares of common stock from
    us solely to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions.</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common stock to be outstanding after the
    offering</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,610,524 shares
    of our common stock.&nbsp;&nbsp;If the underwriters&rsquo; over-allotment option is exercised in full, the total number of
    shares of common stock outstanding immediately after this offering would be 8,510,524.</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 2.4pt; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use of Proceeds</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expect to use
    the net proceeds from the sale of securities pursuant to this offering for working capital and general corporate purposes
    which may include, without limitation, engaging in acquisitions or other business combinations or investments, sales and marketing
    activities, general and administrative matters and capital expenditures. Please see &ldquo;Use of Proceeds&rdquo; below.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 28%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk Factors</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 71%; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    the section entitled &ldquo;Risk Factors&rdquo; beginning on page 8 of this prospectus for a discussion of factors you should
    carefully consider before deciding to invest in our securities.</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq Capital Market symbol and trading</B></FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our common stock
    is listed on The Nasdaq Capital Market under the symbol &ldquo;SGBX.&rdquo; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
number of shares of common stock shown above to be outstanding after this offering is based on 1,610,524&nbsp;shares outstanding
as of May 1, 2020.</FONT></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Unless
otherwise stated all share and per share amounts in this prospectus have been adjusted to reflect the 1-for-20 reverse stock split
we effected on February 5, 2020.</FONT></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, unless we indicate otherwise, all information in this prospectus:</FONT></P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0 0 42.9pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no exercise by the underwriters of their over-allotment option;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no <FONT STYLE="background-color: white">exercise of the representative&rsquo;s warrants to be issued to the representative
    of the underwriters in this offering;</FONT></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    53,190 shares of our common stock issuable upon the exercise of outstanding warrants with a weighted average exercise price
    of $35.14;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 53,170
    shares of our common stock issuable upon the exercise of outstanding options with a weighted average exercise price of $81.20;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 9,187 restricted
    stock units (vested and unvested) granted under our SG Blocks, Inc. Stock Incentive Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
the extent that any options or warrants are exercised, new options or other equity awards are issued under our equity incentive
plan, or we otherwise issue additional shares of common stock or convertible debt securities in the future, there will be further
dilution to new investor</FONT></P>
</DIV>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 97%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_003"></A>SUMMARY
CONSOLIDATED FINANCIAL DATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following summary consolidated financial data as of or for the fiscal years ended December&nbsp;31, 2019 and 2018 have been derived
from our audited consolidated financial statements incorporated by reference in this prospectus. The historical financial data
presented below is not necessarily indicative of our financial results in future periods. You should read the summary consolidated
financial data together with our consolidated financial statements and the related notes and &ldquo;Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations&rdquo; and other information included elsewhere in this prospectus
or otherwise incorporated by reference. Our consolidated financial statements are prepared and presented in accordance with U.S.
generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Year ended<BR> December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">Statement of Operations Data:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Total Revenue</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2,984,835</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">8,190,712</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total Cost of Revenue</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,307,488</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">7,647,979</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Gross Profit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">677,347</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">542,733</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 0.25in">Payroll and related expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,392,587</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,166,212</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 0.25in">General and administrative expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,788,276</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,760,655</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 0.25in">Marketing and business development expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">240,557</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">387,400</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 0.25in">Pre-project expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">21,286</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">74,629</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Goodwill impairment</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,938,653</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Total</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">7,381,359</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,388,896</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Operating loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(6,704,012</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,846,163</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Total other (expense) income, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(216,528</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,142</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Income tax expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Net loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(6,920,540</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(4,844,021</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net loss per share &ndash; basic and diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(22.85</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(22.74</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Weighted average shares outstanding- basic and diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">302,844</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">213,002</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <BR> 2019 Unaudited</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 11pt; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma<BR> (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma As<BR> Adjusted(2)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">Balance Sheet Data:</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,625,671</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,134,871</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">16,609,871</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,906,809</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,416,009</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">17,891,009</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property, plant and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,747</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,747</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,747</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,634,611</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,143,811</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,618,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,274,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,274,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,274,462</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,579</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,105</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">76,105</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,932,387</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,437,061</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,852,061</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(17,583,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(17,583,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(17,583,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Liabilities and Stockholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,634,611</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,143,811</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,618,811</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 6.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On a pro forma basis
    to give effect to the sale by us of 440,000 shares of common stock in the April 2020 Offering at a public offering price of
    $4.25 per share, and the receipt of net proceeds of approximately $1,509,200, after deducting the estimated underwriting discounts
    and commissions and estimated offering expenses, and the addition of 12,672 shares of common stock upon the vesting of restricted
    stock units subsequent to December 31, 2019. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On a pro forma as
    adjusted basis to give effect to the sale by us of 6,000,000 shares of common stock in this offering at the public offering
    price of $2.50 per share, after deducting the estimated underwriting discounts and commissions and estimated offering expenses.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>
</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_004"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>An
investment in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described
below together with all of the other information contained or incorporated by reference in this prospectus, including our consolidated
financial statements and the related notes, before making a decision to invest in our securities. You should also consider the
risks, uncertainties and assumptions discussed under Item 1A, &ldquo;Risk Factors,&rdquo; in Part I of our Annual Report on Form
10-K for the year ended December 31, 2019 and any updates or other risks contained in other filings that we may make with the
Securities and Exchange Commission (&ldquo;SEC&rdquo;) after the date of this prospectus, all of which are incorporated herein
by reference, and may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future.
If any of these risks actually occur, our business, results of operations and financial condition could suffer. In that case,
the market price of our common stock could decline, and you may lose all or part of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>You
will experience immediate and substantial dilution in the book value per share of the common stock you purchase.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
public offering price per share of our common stock will be substantially higher than the net tangible book value per share of
our common stock immediately prior to the offering. After giving effect to the sale of the shares of our common stock in this
offering, purchasers of our common stock in this offering will incur immediate dilution in the net tangible book value of the
common stock they acquire. For a further description of the dilution that investors in this offering will experience, see &ldquo;Dilution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, to the extent that outstanding warrants (including the exercise of any common warrants) or options have been or may
be exercised, the Debenture is converted into shares of common stock or other shares issued, you may experience further dilution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
management will have broad discretion over the use of proceeds from this offering and may not use the proceeds effectively.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
management will have broad discretion over the use of proceeds from this offering. The net proceeds from this offering will be
used <FONT STYLE="background-color: white">primarily for working capital and general corporate purposes and engaging in acquisitions
or other business combinations or investments, sales and marketing activities, general and administrative matters and capital
expenditures</FONT>. Our management will have considerable discretion in the application of the net proceeds, and you will not
have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. The failure
by our management to apply these funds effectively could result in financial losses that could have a material adverse effect
on our business and cause the price of our common stock to decline.&nbsp; The net proceeds may be used for corporate purposes
that do not improve our operating results or enhance the value of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Relating to our Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
auditor&rsquo;s report on our consolidated financial statements contains an explanatory paragraph regarding our ability to continue
as a going concern.&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
consolidated financial statements as of December 31, 2019 have been prepared under the assumption that we will continue as a going
concern. In addition, our independent registered public accounting firm has issued a report that includes an explanatory paragraph
referring to our recurring losses from operations&nbsp;and negative operating cash flows that raise substantial doubt in our ability
to continue as a going concern. Our consolidated financial statements as of December 31, 2019 did not include any adjustments
that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are not successful in our efforts to increase sales or raise capital, we could experience a shortfall in cash over the next&nbsp;twelve&nbsp;months,
and our ability to obtain additional financing on acceptable terms, if at all, may be limited.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On&nbsp;December
31, 2019&nbsp;and&nbsp;2018, we had cash and cash equivalents and a short-term investment, collectively, of $1,625,671&nbsp;and
$1,368,395, respectively. However, during the fiscal years ended&nbsp;December 31, 2019&nbsp;and&nbsp;2018, we reported a net
loss of $6,920,540&nbsp;and $4,844,021, respectively, and used $2,815,621&nbsp;and $3,452,234&nbsp;of cash for operations, respectively.
Despite raising capital in the April 2020 Offering, if we are not successful with our efforts to increase revenue, we could experience
a shortfall in cash over the next&nbsp;twelve&nbsp;months. If there is a shortfall, we may be forced to reduce operating expenses,
among other steps, all of which would have a material adverse effect on our operations going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may also seek to obtain debt or additional equity financing to meet any cash shortfalls. The type, timing and terms of any financing
we may select will depend on, among other things, our cash needs, the availability of other financing sources and prevailing conditions
in the financial markets. However, there can be no assurance that we will be able to secure additional funds if needed and that,
if such funds are available, the terms or conditions would be acceptable to us. If we are unable to secure additional financing,
further reduction in operating expenses might need to be substantial in order for us to ensure enough liquidity to sustain our
operations. Any equity financing would be dilutive to our stockholders. If we incur debt, we will likely be subject to restrictive
covenants that significantly limit our operating flexibility and require us to encumber our assets. If we fail to raise sufficient
funds and continue to incur losses, our ability to fund our operations, take advantage of strategic opportunities, or otherwise
respond to competitive pressures will be significantly limited. Any of the above limitations could force us to significantly curtail
or cease our operations, and you could lose all of your investment in our common stock. These circumstances have raised substantial
doubt about our ability to continue as a going concern, and continued cash losses may risk our status as a going concern. Our
consolidated financial statements do not include any adjustments that might be necessary should we be unable to continue as a
going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
have incurred net losses in prior periods, and there can be no assurance that we will generate income in the future, or that we
will be able to successfully achieve or maintain our growth strategy.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
ability to achieve profitability will depend upon our ability to generate and sustain substantially increased revenues. We may
continue to incur operating losses in the future as we execute our growth strategy. Although we expect that our expenses will
decline due to our new business model, there can be no assurance that our revenue from royalties will exceed our expenses, especially
since we anticipate that most of our expenses will be fixed expenses that will not be dependent&nbsp;upon revenue generated. The
likelihood that we will generate net income in the future must be considered in light of the difficulties facing the construction
industry as a whole, economic conditions and the competitive environment in which we operate. Our operating results for future
periods are subject to numerous uncertainties, and we may not achieve sufficient revenues to sustain or increase profitability.
In addition, we may be unable to successfully achieve or maintain our growth strategy, including our ability to expand into new
geographic markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>There
can be no assurance that our collaboration with Transcend will be successful and generate revenue. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
March 30, 2020, we entered into a non-binding Memorandum of Understanding with Transcend to provide joint products and services.
Products that are expected to be implemented include modular primary care medical units, COVID-19 diagnostic testing units, quarantine
living units, as well as drive through testing units at employer onsite clinics and community hospitals. The Memorandum of Understanding
does not specify a quantity of units to be built or provide for any guarantee of services by either party. There can be no assurance
that the collaboration will continue, that it will yield the anticipated benefits or generate significant revenue, if any, that
we will be able to build the anticipated medical and testing units in a timely manner or that the need for such units will continue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>There
can be no assurance that our Distributorship Agreement with Osang will generate revenue.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
April 30, 2020, we entered into the Distributorship Agreement with Osang that provides us with the non-exclusive right to distribute
Osang&rsquo;s GeneFinder COVID-19 Plus RealAmp Kit in the United States for a stated term of one (1) year. The Distribution Agreement
does not guarantee us a specific quantity of kits to sell or a customer list, requires us to pay for 100% of the purchase order
prior to delivery (though we do not expect to make any cash outlays for product and expect instead to require our customers to
make such cash outlays) and may be terminated by either party at any time on thirty (30) days&rsquo; notice. To date, we have
never sold any medical devices or kits and there can be no guarantee that we will be able to establish a sales force, establish
distribution channels or solicit customers for the kits. There can be no assurance that the Distributorship Agreement will continue,
that it will yield the anticipated benefits or generate significant revenue, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Product
liability and other claims with respect to Osang&rsquo;s GeneFinder COVID-19 Plus RealAmp Kit may have material adverse effects
on our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Companies
that distribute medical tests, are generally subject to risks related to product liability litigation and other claims or litigation.
Product liability risks are inherent in marketing and sale of pharmaceutical products. Even though we are not currently subject
to any product liability claims such claims could arise at a later date. Though Osang has agreed to indemnify us for certain product
liability claims, claims arising under the Distributorship Agreement must be arbitrated in Singapore and enforcement of such indemnification
provisions would be time-consuming for our management and lead to significant costs and losses, which would adversely affect our
business, results of operations, cash flows, financial condition, and/or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
though we intend to obtain product liability insurance and Osang has agreed to indemnify us for certain claims arising out of
the manufacture of the kits, there can be no assurance that such insurance coverage will continue to be available on reasonable
commercial terms or that such insurance or indemnification will prove adequate. If sufficient insurance coverage is not obtained
covering product liability, or if such future litigation or investigation exceeds our insurance coverage, we could be subject
to significant liabilities, which could have material adverse effect on our business, results of operations, cash flows, financial
condition, and/or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
residential construction business model depends upon a third-party licensee who is outside our control.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We&nbsp;entered
into an exclusive license agreement with CPF, pursuant to which we granted CPF an exclusive license solely within the United States
and its legal territories to commercialize our technology, intellectual property, any improvements thereto, and any related permits,
in order to develop and commercialize products within the field of design and project management platforms for residential use,
including, without limitation, single-family residences and multi-family residences, but specifically excluding military housing.
Under the terms of the License Agreement, CPF is to provide us with royalties based upon its sale of products that utilize the
licensed technology. Inasmuch as CPF has an exclusive license in the United States, which is the only territory to date where
we have been retained to construct products for use for residences, unless we were to either expand residential construction product
sales to territories outside of the United States or enter into licensing arrangements similar to that with CPF for sales of products
that utilize our technology outside of the United States for residential use or in the United States for business not cover by
the License, such as military residences and commercial and industrial construction, we will be totally dependent upon CPF for
our revenue for residential construction. CPF is an independent entity and we cannot control the amount or timing of resources
that it devotes to such commercialization efforts. CPF may not assign as great a priority to such commercialization efforts or
pursue them as diligently as we would if we were undertaking such commercialization ourselves. If CPF or any other licensee fails
to devote sufficient time and resources to such commercialization efforts, or if its performance is substandard our ability to
generate revenue may be adversely affected. CPF may also have relationships with other commercial entities, some of whom may compete
with us. If CPF assists our competitors at our expense, our competitive position would be harmed. In addition, upon certain extraordinary
events, CPF is entitled to terminate the license agreement in which case we would be forced to incur the costs to commercialize
products for residential construction unless another licensee were found.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
residential construction business is difficult to evaluate because we are currently focused on a new business model and have very
limited operating history and limited information.</I></B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We&nbsp;recently
engaged in a new licensing business model for our residential construction business in the United States. We have entered into
one license agreement for use of our technology for construction of residences in the United States and if successful, we intend
to expand our model and enter into additional similar agreements. There is a risk that we will be unable to successfully generate
revenue from this new business model and that we will be unable to enter into additional licensing agreements or that any additional
agreements that we enter into will be on favorable terms. Although we believe that we will experience cost savings from this new
business model resulting in greater net income since we will no longer require the same level of capital, personnel and equipment
as was required from our prior residential construction business model, there can be no assurance that we will experience the
level of cost savings that we anticipate or generate the income that we anticipate. We are subject to many risks associated with
this new business model such as our dependence upon licensees to commercialize products that utilize our technology. There is
no assurance that the licensees activities will be successful or will result in any revenues or profit. Even if we generate revenue,
there can be no assurance that we will be profitable. We are subject to the risks inherent to the operation of a new business
enterprise, and cannot assure you that we will be able to successfully address these risks.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>In
December 2019, a novel strain of coronavirus, COVID-19, was reported to have surfaced in Wuhan, China. Since then, the COVID-19
coronavirus has spread to multiple countries, including the United States. The impact of the COVID-19 coronavirus outbreak, or
similar global health concerns, could negatively impact our ability to source certain products, impact product pricing, impact
our customers&rsquo; ability or that of our licensee to obtain financing or have a negative impact on our business.</I></B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
March 2020, the World Health Organization declared COVID-19 a global pandemic.&nbsp;This contagious disease outbreak, which has
continued to spread, and the related adverse public health developments, have adversely affected work forces, economies and financial
markets globally. Our use of third-party suppliers for production and shipping of certain products could be negatively impacted
by the regional or global outbreak of illnesses, including the COVID-19 coronavirus outbreak. To date, we have experienced some
delays in projects due to COVID-19. Any quarantines, the timing and length of containment and eradication solutions, travel restrictions,
absenteeism by infected workers, labor shortages or other disruptions to our suppliers and their contract manufacturers or our
customers or our licensee, CPF, would likely adversely impact our sales and operating results and result in further project delays.
In addition, the pandemic could result in an economic downturn that could affect the ability of our customers and licensees to
obtain financing and therefore impact demand for our products. Order lead times could be extended or delayed and pricing could
increase.&nbsp; Some products or services may become unavailable if the regional or global spread were significant enough to prevent
alternative sourcing. Accordingly, we are considering alternative product sourcing in the event that product supply becomes problematic.&nbsp;We
expect this global pandemic to have an impact on our revenue and our results of operations, the size and duration of which we
are currently unable to predict.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the outbreak of the COVID-19&nbsp;coronavirus could disrupt our operations due to absenteeism by infected or ill members
of management or other employees, or absenteeism by members of management and other employees who elect not to come to work due
to the illness affecting others in our office or other workplace, or due to quarantines. COVID-19&nbsp;illness could also impact
members of our Board of Directors resulting in absenteeism from meetings of the directors or committees of directors, and making
it more difficult to convene the quorums of the full Board of Directors or its committees needed to conduct meetings for the management
of our affairs.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
global outbreak of the COVID-19&nbsp;coronavirus continues to rapidly evolve. The extent to which the COVID-19&nbsp;coronavirus
may impact our business and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted
with confidence, such as the ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions and
social distancing in the United States and other countries, business closures or business disruptions and the effectiveness of
actions taken in the United States and other countries to contain and treat the disease.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
requirements of being a public company may strain our resources, divert management&rsquo;s attention and affect our ability to
attract and retain qualified board members.</I></B></FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to the reporting and corporate governance requirements of the Exchange Act, the listing requirements of the Nasdaq
Capital Market and other applicable securities rules and regulations, including the Sarbanes-Oxley Act and the Dodd-Frank Act.
Compliance with these rules and regulations will increase our legal and financial compliance costs, make some activities more
difficult, time-consuming or costly and increase demand on our systems and resources. Among other things, the Exchange Act requires
that we file annual, quarterly and current reports with respect to our business and results of operations and maintain effective
disclosure controls and procedures and internal control over financial reporting. In order to continue to maintain our disclosure
controls and procedures and internal control over financial reporting to meet this standard, significant resources and management
oversight may be required. As a result, management&rsquo;s attention may be diverted from other business concerns, which could
harm our business, financial condition, results of operations and prospects. We also may need to further expand our legal and
finance departments in the future, which will increase our costs and expenses.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty
for public companies, increasing legal and financial compliance costs and making some activities more time-consuming. These laws,
regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result,
their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could
result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure
and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment
may result in increased general and administrative expense and a diversion of management&rsquo;s time and attention from revenue-generating
activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities
intended by regulatory or governing bodies, regulatory authorities may initiate legal proceedings against us and our business
and prospects may be harmed. As a result of disclosure of information in the filings required of a public company, our business
and financial condition are more visible, which may result in threatened or actual litigation, including by competitors and other
third parties. If such claims are successful, our business, financial condition, results of operations and prospects could be
harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources
necessary to resolve them, could divert the resources of our management and harm our business, financial condition, results of
operations and prospects.</FONT></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
issuance of shares of our common stock upon the exercise of outstanding options, warrants and restricted stock units may dilute
the percentage ownership of the then-existing stockholders and may make it more difficult to raise additional equity capital.</I></B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of December 31, 2019, there are outstanding options and warrants to purchase 53,170 and 53,190 shares of common stock, respectively,
in addition to 21,859 vested and unvested restricted stock units. The exercise of such options and warrants and the vesting of
restricted stock units would dilute the then-existing stockholders&rsquo; percentage ownership of our stock, and any sales in
the public market of common stock underlying such securities could adversely affect prevailing market prices for the common stock.
Moreover, the terms upon which we would be able to obtain additional equity capital could be adversely affected because the holders
of our options and warrants can be expected to exercise them at a time when we would, in all likelihood, be able to obtain any
needed capital on terms more favorable to us than those provided by such securities.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
are dependent on the services of key personnel, and the unexpected loss of their services may adversely affect our operations.</I></B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
success depends highly upon the personal efforts and abilities of our senior management team, specifically the efforts of Paul
M. Galvin, our Chief Executive Officer,&nbsp;Gerald Sheeran, our Acting Chief Financial Officer, and Stevan Armstrong, our Chief
Technology Officer. The Company has entered into employment agreements with Mr. Galvin. The employment agreement with Mr. Galvin
provides for two-year terms, with automatic renewal after the end of such term. The loss of the services of one or more of these
individuals could have a material adverse effect on our business.&nbsp;Our ability to achieve profitability and generate increased
revenue will depend upon our ability to retain, and, if necessary, attract experienced management personnel.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
loss of&nbsp;one&nbsp;or a few customers could have a material adverse effect on us.</I></B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
few customers have in the past, and may in the future, account for a significant portion of our revenues in any&nbsp;one&nbsp;year
or over a period of several consecutive years. For example, for the year ended December 31,&nbsp;2019, approximately&nbsp;78%
of our revenue was generated from&nbsp;two&nbsp;customers. Although we have contractual relationships with many of our significant
customers, our customers may unilaterally reduce or discontinue their contracts with us at any time. The loss of business from
a significant customer could have a material adverse effect on our business, financial condition, results of operations and cash
flows.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
rely on certain vendors to supply us with materials and products that, if&nbsp;we were unable to obtain, could adversely affect
our business.</I></B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have relationships with key materials vendors, and we rely on suppliers for our purchases of products from them.&nbsp;&nbsp;Any
inability to obtain materials or services in the volumes required and at competitive prices from our major trading partners, the
loss of any major trading partner or the discontinuation of vendor financing (if any) may seriously harm our business because
we may not be able to meet the demands of our customers on a timely basis in sufficient quantities or at all.&nbsp;&nbsp;Other
factors, including reduced access to credit by our vendors resulting from economic conditions, may impair our vendors&rsquo; ability
to provide products in a timely manner or at competitive prices.&nbsp;&nbsp;We also rely on other vendors for critical services
such as transportation, supply chain and professional services.&nbsp;&nbsp;Any negative impacts to our business or liquidity could
adversely impact our ability to establish or maintain these relationships.&nbsp;For the years ended December 31, 2019 and 2018,
74% and 55%, respectively of our cost of revenue related to three and two vendors, respectively.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>An
impairment of goodwill could have a material adverse effect on our financial condition and results of operations.</I></B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
December 31, 2019, we had $1,223,520 of goodwill. We perform an impairment test of our goodwill annually during the fourth quarter
of our fiscal year or when events occur or circumstances change that would more-likely-than-not indicate that goodwill might be
impaired. Factors that may be considered a change in circumstances, indicating that the carrying value of our goodwill may not
be recoverable, include a decline in stock price and market capitalization, reduced future cash flow estimates and slower growth
rates in our industry. Our annual impairment tests resulted in an impairment of goodwill during fiscal 2019 in the amount of $2,938,653.
The annual impairment test&nbsp;during fiscal&nbsp;2018 resulted in no impairment being recorded. Deterioration in estimated future
cash flows in our reporting unit could result in further future goodwill impairment. Changes to our business strategy, changes
in industry or market conditions, changes in operating performance or other indicators of impairment could cause us to record
a significant impairment charge during the period in which the impairment is determined, negatively impacting our results of operations
and financial position.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
currently are, and may in the future be, subject to legal proceedings or investigations, the resolution of which could negatively
affect our profitability and cash flows in a particular period.</I></B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
nature of our operations exposes us to possible litigation claims, including disputes relating to our operations and commercial
and contractual arrangements. Although we make every effort to avoid litigation, these matters are not totally within our control.
We will contest these matters vigorously and will make insurance claims where appropriate, but because of the uncertain nature
of litigation and coverage decisions, we cannot predict the outcome of these matters. The costs associated with litigation matters
could have a material adverse effect on our financial condition and profitability. In addition, our profitability or cash flow
in a particular period could be affected by an adverse ruling in any litigation currently pending in the courts or by litigation
that may be filed against us in the future. We are also subject to environmental and other government regulation, which could
result in administrative proceedings in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Relating to our Business and Industry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
and CPF are dependent on the availability and skill of subcontractors, their willingness to work with us, and their selection
of, and ability to obtain, suitable and quality building materials.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
and CPF&nbsp;will rely on subcontractors to perform the actual construction of our building projects and, in many cases, to select
and obtain raw materials. Despite detailed specifications and quality control procedures, in some cases, improper construction
processes or defective materials may be used to finish construction of our building projects. We and CPF may need to spend money
to remediate such problems when they are discovered. Defective products can result in the need to perform extensive repairs to
large numbers of buildings. Though subcontracts are written to protect from substandard performance or materials, pervasive problems
could adversely affect CPF&rsquo;s business and therefore our ability to generate royalty income. Our revenue from our CPF is
based upon the gross revenue it receives from product sales which is exclusive of amounts repaid or credited by reason of rejection
or returns. The inability to contract with skilled subcontractors or general contractors at reasonable costs and on a timely basis
could limit our or CPF&rsquo;s ability to construct and deliver buildings and could erode our profit margins and adversely affect
our results of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We&nbsp;depend
on third parties for transportation services, and limited availability or increases in costs of transportation could adversely
affect our business and operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
business depends on the transportation of a large number of products, via railroad or truck. We rely primarily on third parties
for transportation of the products we manufacture or distribute and for the delivery of our raw materials. We are also subject
to seasonal capacity constraints, which may be severely reduced due to COVID-19 coronavirus, and weather-related delays for both
rail and truck transportation. If any of our third-party transportation providers were to fail to deliver raw materials to us
or our Modules to our customers in a timely manner, we may be unable to complete projects in a timely manner and may, among other
things, incur penalties for late delivery or be unable to use the Modules as intended. In addition, if any of these third parties
were to cease operations or cease doing business with us, we may be unable to replace them at reasonable cost. Any failure of
a third-party transportation provider to deliver raw materials to us or finished Modules to our customers in a timely manner could
harm our reputation, negatively affect our customer relationships, and have a material adverse effect on our operating results,
cash flows, and financial condition. Additionally, an increase in transportation rates or fuel surcharges could adversely affect
our sales, profitability, and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may have difficulty protecting our proprietary manufacturing processes, which could adversely affect our ability to compete.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
use a proprietary manufacturing process that allows us to be code-compliant in our&nbsp;SGBlocks&trade;&nbsp;product. Such manufacturing
process is unique to the construction industry and is important to ensure our continued success, and we cannot assure you that
our efforts to protect our proprietary rights will be sufficient or effective. If other companies replicate our methodology, we
could lose our competitive advantage. Any future patent or trademark applications may not lead to issued patents and registered
trademarks in all instances. We also cannot be assured that the scope of any patents issued in the future will be sufficiently
broad to offer meaningful protection. Others may develop or patent similar or superior technologies, products or services, and
our intellectual property rights may be challenged, invalidated, misappropriated or infringed by others. If we are unable to protect
and maintain our intellectual property rights, or if there are any successful intellectual property challenges or infringement
proceedings against us, our business and revenue could be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Expansion
of our operations may strain resources, and our failure to manage growth effectively could adversely impact our operating results
and harm our ability to attract and retain key personnel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increased
orders for our Modules have placed, and may continue to place, a strain on our operational, financial, and managerial resources
and personnel. In addition, execution of our growth strategy will require further substantial capital and effective planning.
Significant rapid growth on top of our current operations could greatly strain our internal resources, leading to a lower quality
of customer service, reporting problems, and delays, resulting in a loss of market share and other problems that could adversely
affect our financial performance. Our efforts to grow could place an additional strain on our personnel, management systems, liquidity,
and other resources. If we do not manage our growth effectively, our operations could be adversely affected, resulting in slower,
no or negative growth, critical shortages of cash and a failure to achieve or sustain profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
clients may adjust, cancel or suspend the contracts in our backlog; as such, our backlog is not necessarily indicative of our
future revenues or earnings. In addition, even if fully performed, our backlog is not a good indicator of our future gross margins.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Backlog
represents the total dollar amount of revenues we expect to record in the future as a result of performing work under contracts
we have been awarded. Backlog may fluctuate significantly due to the timing of orders or awards for large projects and is not
necessarily indicative of future backlog levels or the rate at which backlog will be recognized as revenue. We include in backlog
only those contracts for which we have reasonable assurance that the customer can obtain the permits for construction and can
fund the construction.&nbsp;As of December 31, 2018, our backlog totaled approximately $97.7 million and as of&nbsp;December 31,
2019, our backlog totaled approximately $17.6 million. The decrease in backlog at December 31, 2019 from December 31, 2018 is
primarily attributable to us moving a contract of approximately $25 million out of backlog after receiving a cancellation notice
from the customer and moving two contracts of approximately $70 million out of backlog due to the exclusive License Agreement.
Our backlog includes one large contract entered into by us during the third quarter of 2019 in the amount of approximately&nbsp;$17
million&nbsp;as described in more detail in &ldquo;Note&nbsp;10&mdash;Construction&nbsp;Backlog&rdquo; of the notes to our consolidated
financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020.&nbsp;We cannot provide assurance
that our backlog will be realized as revenues in the amounts reported or, if realized, will result in profits. In accordance with
industry practice, substantially all of our contracts are subject to cancellation, termination or suspension at our customer&rsquo;s
discretion. In the event of a project cancellation, we generally would not have a contractual right to the total revenue reflected
in our backlog. Projects can remain in backlog for extended periods of time because of the nature of the project and the timing
of the particular services required by the project. In addition, the risk of contracts in backlog being cancelled or suspended
generally increases during periods of widespread economic slowdowns or in response to changes in commodity prices.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
contracts in our backlog are subject to changes in the scope of services to be provided and adjustments to the costs relating
to the contracts. The revenue for certain contracts included in backlog is based on estimates. Additionally, our performance of
our individual contracts can affect greatly our gross margins and, therefore, our future profitability. We can provide no assurance
that the contracts in backlog, assuming they produce revenues in the amounts currently estimated, will generate gross margins
at the rates we have realized in the past.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
liability for estimated warranties may be inadequate, which could materially adversely affect our business, financial condition
and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to construction defect and warranty claims arising in the ordinary course of business. These claims are common in
the construction industry and can be costly. At this time, our third-party providers offer guarantees and warranties in accordance
with industry standards that flow through to our clients. A large number of warranty claims could have a material adverse effect
on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
can be adversely affected by failures of persons who act on our behalf to comply with applicable regulations and guidelines.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we expect all of our associates (i.e., employees), officers and directors to comply at all times with all applicable laws, rules
and regulations, there are instances in which subcontractors or others through whom we do business may engage in practices that
do not comply with applicable regulations or guidelines.&nbsp;&nbsp;It is possible that our associates may become aware of these
practices but do not take steps to prevent them.&nbsp;&nbsp;If we learn of practices relating to buildings constructed on our
behalf that do not comply with applicable regulations or guidelines, we will move actively to stop the non-complying practices
as soon as possible, and we will take disciplinary action with regard to our associates who were aware of the practices, including
in some instances terminating their employment. However, regardless of the steps we take, we may be subject to fines or other
governmental penalties, and our reputation may be negatively affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The</I></B>&nbsp;<B><I>cyclical
and seasonal nature of the construction industry causes our revenues and operating results to fluctuate, and we expect this cyclicality
and seasonality to continue in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The&nbsp;construction
industry is highly cyclical and seasonal and is influenced by many international, national and regional economic factors, including
the availability of consumer and wholesale financing, which may be severely reduced due to COVID-19 coronavirus, seasonality of
demand, consumer confidence, interest rates, income levels and general economic conditions, including inflation and recessions.
As a result of the foregoing factors, the revenues and operating results we derive from customers and CPF will fluctuate and we
currently expect them to continue to fluctuate in the future. Moreover, we have experienced, and may continue to experience, operating
losses during cyclical downturns in the construction market. These and other economic factors could have a material adverse effect
on demand for our products and our financial condition and operating results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our&nbsp;business
depends on the construction industry and general business, financial market and economic conditions.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
construction industry is cyclical and significantly affected by changes in general and local economic and real estate conditions,
such as employment levels, consumer confidence, demographic trends, housing demand, inflation, deflation, interest rates and credit
availability. Changes in these general and local economic conditions or deterioration in the broader economy could negatively
impact the level of purchases, capital expenditures and creditworthiness of our indirect customers and suppliers to CPF s, and,
therefore, our royalty income and financial condition, results of operations and cash flows. Changes in these economic conditions
may affect some of our regions or markets more than others. If adverse conditions affect our larger markets, they could have a
proportionately greater impact on us than on some other companies. In addition, any uncertainty regarding global economic conditions
may have an adverse effect on the results of operations and financial condition of us or our customers, distributors and suppliers,
such as negative effects of currency exchange fluctuations. A shortage of labor in the construction industry could also have an
impact on our financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
business relies on private investment and a slower than expected economy may adversely affect our results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
significant portion of our sales and those of CPF are for projects with non-public owners, such as non-residential builders and
home builders who make investments with private funds into their projects. Construction spending is affected by their customers&rsquo;
ability to finance projects, which may be severely reduced due to the COVID-19 coronavirus. Residential and nonresidential construction
could decline if companies and consumers are unable to finance construction projects or if the economy slows or is stalled, which
could result in delays or cancellations of capital projects. If the economy slows, or if housing starts and nonresidential projects
do not increase, sales of our products directly by us to consumers or by CPF and related services may decline, and our financial
position, results of operations and liquidity could be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>A
material disruption at&nbsp;one&nbsp;of our suppliers&rsquo; facilities could prevent us from meeting customer demand, reduce
our sales and negatively affect our overall financial results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
of the following events could cease or limit operations unexpectedly: fires, floods, earthquakes, hurricanes, on-site or off-site
environmental incidents or other catastrophes; global pandemic; utility and transportation infrastructure disruptions; labor difficulties;
other operational problems; or war, acts of terrorism or other unexpected events. Any downtime or damage at our suppliers&rsquo;
facilities could prevent us from meeting customer demand for our products or require us to make more expensive purchases from
a competing supplier. If our suppliers were to incur significant downtime, our ability to satisfy customer requirements could
be impaired, resulting in customers seeking products from other distributors, as well as decreased customer satisfaction and lower
sales and operating income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Environmental,
health and safety laws and regulations and any changes to, or liabilities arising under, such laws and regulations could have
a material adverse effect on our financial condition, results of operations and liquidity.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to a variety of federal, state and local laws and regulations relating to, among other things: the release or discharge
of materials into the environment; the management, use, generation, treatment, processing, handling, storage, transport or disposal
of solid and hazardous wastes and materials; and the protection of public and employee health and safety and the environment.
These laws and regulations may expose us to liability for the conduct of others or for our actions, even if such actions complied
with all applicable laws at the time these actions were taken. These laws and regulations may also expose us to liability for
claims of personal injury or property or natural resource damage related to alleged exposure to, or releases of, regulated or
hazardous materials. The existence of contamination at properties we own, lease or operate could also result in increased operational
costs or restrictions on our ability to use those properties as intended, including for purposes of construction materials distribution.
In addition, because our properties are generally situated adjacent to or near industrial companies, our properties may be at
an increased risk of having environmental contaminants from other properties spill or migrate onto or otherwise affect our properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Despite
our compliance efforts, there is an inherent risk of liability in the operation of our business, especially from an environmental
standpoint, and, from time to time, we may be in noncompliance with environmental, health and safety laws and regulations. These
potential liabilities or non-compliances could have an adverse effect on our operations and profitability. In some instances,
we must have government approvals, certificates, permits or licenses in order to conduct our business, which may require us to
make significant capital, operating and maintenance expenditures to comply with environmental, health and safety laws and regulations.
Our failure to obtain and maintain required approvals, certificates, permits or licenses or to comply with applicable governmental
requirements could result in sanctions, including substantial fines or possible revocation of our authority to conduct some or
all of our operations. The cost of complying with such laws could have a material adverse effect on our financial condition, results
of operations and liquidity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
business may be subject to economic and political risks of operating and obtaining supplies from foreign countries, including
adverse impact of changes in international trade and tariff policies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
operate in and source some of our products from outside of the United States, and our suppliers may also rely upon non-domestic
products. As such, any significant changes to, among other things, the general political and social conditions in foreign counties
in which we maintain operations or sourcing relationships, unfavorable changes in U.S. trade legislation and regulation, the recent
outbreak of the COVID-19&nbsp;coronavirus, the imposition of governmental economic sanctions on countries in which we do business
or other trade barriers, threats of war, terrorism or governmental instability, labor disruptions, currency controls, fluctuating
exchange rates with respect to contracts not denominated in U.S. dollars and unanticipated or unfavorable changes in government
policies with respect to laws and regulations, anti-inflation measures and method of taxation. If we are unable to navigate foreign
regulatory environments, or if we are unable to enforce our contract rights in foreign countries, our business could be adversely
impacted. Any of these events could interrupt our business and cause operational disruptions, increase our costs of operations,
reduce our sales or otherwise have an adverse effect on our operating performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
U.S. government has indicated its intent to alter its approach to trade policy, including, in some instances, to revise, renegotiate
or terminate certain multilateral trade agreements. It has also imposed new tariffs on certain foreign goods and raised the possibility
of imposing additional increases or new tariffs on other goods. Such actions have, in some cases, led to retaliatory trade measures
by certain foreign governments. Such policies could make it more difficult or costly for us to do business in or procure products
from those countries. In turn, we may need to raise prices or make changes to our operations, which could negatively impact our
revenue or operating results. At this time, it remains unclear what additional actions, if any, will be taken by the U.S. government
or foreign governments with respect to tariff and international trade agreements and policies, and we cannot predict future trade
policy or the terms of any revised trade agreements or any impact on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
operating results will be subject to fluctuations and are inherently unpredictable.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
order to return to profitability, we will need to generate and sustain higher revenue while maintaining reasonable cost and expense
levels. In our most recent quarter, we experienced a loss. We do not know if our revenue will grow, or if it will grow sufficiently
to outpace our expenses, which we expect to increase as we expand our operational capacity. We may not be able to become profitable
on a quarterly or an annual basis. Our quarterly revenue and operating results will be difficult to predict and have in the past
fluctuated from quarter to quarter. The amount, timing and mix of project sales, often for a single medium or large-scale project,
may cause large fluctuations in our revenue and other financial results. Further, our revenue mix of high margin materials sales
versus lower margin projects can fluctuate dramatically quarter to quarter, which may adversely affect our revenue and financial
results in any given period. Finally, our ability to meet project completion schedules for an individual project and the corresponding
revenue impact under the percentage-of-completion method of recognizing revenue, may similarly cause large fluctuations in our
revenue and other financial results. This may cause us to miss any future guidance announced by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
base our planned operating expenses in part on our expectations of future revenue, and a significant portion of our expenses are
fixed in the short-term. If revenue for a particular quarter is lower than we expect, we likely will be unable to proportionately
reduce our operating expenses for that quarter, which would harm our operating results for that quarter. This may cause us to
miss any guidance announced by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Cybersecurity&nbsp;risks
related to the technology used in our operations and other business processes, as well as security breaches of company, customer,
employee and vendor information, could adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
rely on various information technology systems to capture, process, store and report data and interact with customers, vendors
and employees. Despite careful security and controls design,&nbsp;as the prevalence of&nbsp;cyber-attacks continues to increase,&nbsp;our
information technology systems, and those of our third-party providers, could become subject to increased security threats, such
as&nbsp;phishing&nbsp;and&nbsp;malware&nbsp;incidents.&nbsp;Our security measures may be unable to prevent certain security breaches,
and any such network, system, data or other breaches could result in misappropriation of sensitive data, transactional errors,
theft of funds, business disruptions, loss of or damage to intellectual property, loss of customers and business opportunities,
unauthorized access to or disclosure of confidential or personal information (which could cause a breach of applicable data protection
legislation), regulatory fines, penalties or intervention,&nbsp;reputational&nbsp;damage, reimbursement or other compensatory
costs and additional compliance costs, any of which could have a material adverse effect on our reputation, business, financial
condition, results of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
the techniques used to obtain unauthorized access to, or disable, degrade or sabotage, information technologies systems change
frequently, and may not be recognized until after they have been launched against a target, we may be unable to anticipate these
techniques, implement adequate preventative measures or remediate any breach in a timely or effective manner.&nbsp;In addition,&nbsp;the
development and maintenance of preventative or detective measures is costly, and requires ongoing monitoring and updating as technologies
change and efforts to circumvent security measures become more sophisticated. As well as incurring additional costs,&nbsp;sophisticated
hardware and operating system software and applications that we procure from third parties may contain defects in design or manufacture,
including &ldquo;bugs&rdquo; and other problems that could unexpectedly interfere with the operation of the systems, or we may
be unable to successfully integrate and launch new systems as planned without disruptions to our operations.&nbsp;Misuse of internal
applications, theft of intellectual property, trade secrets, funds or other corporate assets and inappropriate disclosure of confidential
information could stem from such incidents.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Despite
our efforts, we remain potentially vulnerable to&nbsp;cyber-attacks and security breaches, and any such attack or breach could
adversely affect our reputation, business, financial condition or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
could suffer adverse tax and other financial consequences if we are unable to utilize our net operating loss&nbsp;carryforwards.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">At&nbsp;December
31, 2019, we had tax net operating loss&nbsp;carryforwards&nbsp;totaling approximately $12.9&nbsp;million.&nbsp;The net operating
loss expires beginning&nbsp;2030&nbsp;through&nbsp;2037&nbsp;for those losses generated in 2017 and prior years. Approximately
$5.5&nbsp;million of such net operating losses will&nbsp;carryforward&nbsp;indefinitely and be available to offset up to 80% of
future taxable income each year.&nbsp;Subsequent&nbsp;to December 31, 2019, the&nbsp;Coronavirus Aid, Relief and Economic Security
Act (&ldquo;CARES Act&rdquo;) was passed, which temporarily removes such 80% limitation for years 2019 and 2020.&nbsp;At&nbsp;December
31, 2019, we had a valuation allowance of $3.1&nbsp;million, primarily related to net operating loss&nbsp;carryforwards&nbsp;that
are not more likely than not to be utilized due to an inability to carry back these losses in most states and short&nbsp;carryforward&nbsp;periods
that exist in certain states. If we are unable to use our net operating losses, we may be required to record charges or reduce
our deferred tax assets, which could have an adverse effect on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Relating to the Construction Sector</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
and CPF may be dependent upon third-party financing, and our financial condition and results of operations could be negatively
affected if additional third-party financing for our customers does not become available</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our&nbsp;business
and earnings depend substantially on our ability and the ability of CPF to obtain financing for the development of their construction
projects, which may be adversely impacted by the recent COVID-19&nbsp;coronavirus outbreak.&nbsp;The availability and cost of
such financing is further dependent on the number of financial institutions participating in the industry, the departure of financial
institutions from the industry, the financial institutions&rsquo; lending practices, the strength of the domestic and international
credit markets generally, governmental policies and other conditions, all of which are beyond our control. In light of the current
economic climate, some of our projects and those of CPF may not be successful in obtaining additional funds in a timely manner,
on favorable terms or at all. The availability of borrowed funds, especially for construction financing, has been greatly reduced,
and lenders may require project developers to invest increased amounts of equity in a project in connection with both new loans
and the extension of existing loans. Unfavorable changes in the availability and terms of financing in the industry will have
a material adverse effect on certain privately financed projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
results of operations also depend on the ability of any potential privately financed licensees to obtain loans for the purchase
of new buildings. Over the past few years, lenders have tightened the credit underwriting standards, which have reduced lending
volumes. If this trend continues, it would negatively impact&nbsp;CPF&rsquo;s&nbsp;sales and our royalty income, which depend
in large part on the availability and cost of financing. In addition, where our potential customers must sell their existing buildings
or real estate in order to develop new buildings, increases in mortgage costs and/or lack of availability of mortgages could prevent
buyers of potential customers&rsquo; existing buildings from obtaining the mortgages they need to complete their purchases, which
would result in our potential customers&rsquo; inability to make purchases from us. If our potential customers cannot obtain suitable
financing, our sales and results of operations would be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
construction industry is highly competitive, and such competition may increase the adverse effects of industry conditions, including
the consolidation of the industry.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
operate in a very competitive environment characterized by competition from numerous local, regional and national builders. We
may compete for financing, raw materials and skilled management and labor resources. A decline in construction starts could adversely
affect demand for our buildings and our results of operations. Increased competition could require us to further increase our
selling incentives and/or reduce our prices, which could negatively affect our profits.&nbsp;We may be unable to successfully
expand into or compete in the markets in new geographic areas. In addition, while we believe our ESR may improve our competitive
position by potentially expediting reviews and approvals by state and local building departments and certifying our specific quality
control and design acceptance criteria, there is no assurance that it will have the desired impact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>There&nbsp;can
be no assurance that Modules or modular construction techniques that utilize our technology and expertise will achieve market
acceptance and grow; thus, the future of our business and the modular construction industry as a whole is uncertain.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There&nbsp;can
be no assurance that we will achieve market acceptance for our technology and expertise or that the modular construction market
will grow. Our business may be disrupted by the introduction of new products and services and is subject to changing consumer
preferences and industry trends, which may adversely affect our ability to plan for the future development and marketing of our
products. Although Modules have particular applications in a wide variety of market segments, there is no assurance that we will
be able to expand our relationship within such market segments or, even if we do, that general market acceptance for our technology
and expertise or Modules will continue to increase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Government
regulations and legal challenges may delay the start or completion of our projects, increase our expenses or limit our building
activities, which could have a negative impact on our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Various
domestic and international rules and regulations concerning building, zoning, sales and similar matters apply to and/or affect
the construction industry.&nbsp;Governmental regulation affects construction activities, as well as sales activities, mortgage
lending activities and other dealings with consumers.&nbsp;&nbsp;These industries also have experienced an increase in state and
local legislation in the United States and regulations that limit the availability or use of land.&nbsp;Municipalities may also
restrict or place moratoriums on the availability of utilities, such as water and sewer taps.&nbsp;In some areas, municipalities
may enact growth control initiatives, which restrict the number of building permits available in a given year.&nbsp;In addition,
we may be required to apply for additional approvals or modify our existing approvals because of changes in local circumstances
or applicable law.&nbsp;If governments in locations in which we operate take actions like the ones described, they could adversely
affect our business by causing delays, increasing our costs or limiting our ability to operate in those areas.&nbsp;Further, we
may experience delays and increased expenses as a result of legal challenges to our proposed projects, whether brought by governmental
authorities or private parties.&nbsp;Failure to comply with laws or regulations applicable to or affecting us, or the passage
in the future of new and more stringent laws affecting us, may adversely affect our financial condition or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
dangers inherent in our operations, such as disruptions to our facilities and project sites, and the limits on insurance coverage
could expose us to potentially significant liability costs and materially interfere with the performance of our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
we believe our insurance coverage is adequate and in line with our industry&rsquo;s standards, all construction, including modular
construction, involves operating hazards that can cause personal injury or loss of life, severe damage to and destruction of property
and equipment and suspension of operations, including, but not limited to, natural or man-made disruptions to our facilities and
project sites.&nbsp;The failure of such structures during and after installation can result in similar injuries and damages. Although
we believe that our insurance coverage is adequate, there can be no assurance that we will be able to maintain adequate insurance
in the future at rates we consider reasonable, or that our insurance coverage will be adequate to cover future claims that may
arise. Claims for which we are not fully insured may adversely affect our working capital and profitability. In addition, changes
in the insurance industry have generally led to higher insurance costs and decreased availability of coverage. The availability
of insurance that covers risks we and our competitors typically insure against may decrease, and the insurance that we are able
to obtain may have higher deductibles, higher premiums and more restrictive policy terms.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Relating to Ownership of our Common Stock and this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
failure to meet the continued listing requirements of the&nbsp;Nasdaq&nbsp;Capital Market could result in a delisting of our common
stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
common stock is listed on the&nbsp;Nasdaq&nbsp;Capital Market&nbsp;(&ldquo;Nasdaq&rdquo; or the &ldquo;Nasdaq&nbsp;Capital Market&rdquo;),
which imposes, among other requirements, a minimum bid requirement. On July 1, 2019, we received a letter from&nbsp;Nasdaq&nbsp;that,
because the closing bid price for our common stock was below $1.00&nbsp;for&nbsp;30&nbsp;consecutive business days, we no longer
met the minimum bid price requirement for continued listing on&nbsp;Nasdaq.&nbsp;On February 21, 2020, we&nbsp;&nbsp;received
written notice from the Listing Qualifications department of Nasdaq&nbsp;notifying us that we had regained compliance with the
minimum bid price and stockholder&rsquo;s equity rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
delisting of our common stock from&nbsp;Nasdaq&nbsp;may make it more difficult for us to raise capital on favorable terms in the
future, or at all. Such a delisting would likely have a negative effect on the price of our common stock and would impair your
ability to sell or purchase our common stock when you wish to do so. Further, if our common stock were to be delisted from&nbsp;Nasdaq,
our common stock would cease to be recognized as a covered security, and we would be subject to additional regulation in each
state in which we offer our securities. Moreover, there is no assurance that any actions that we take to restore our compliance
with the&nbsp;Nasdaq&nbsp;minimum bid requirement would stabilize the market price or improve the liquidity of our common stock,
prevent our common stock from falling below the&nbsp;Nasdaq&nbsp;minimum bid price required for continued listing again or prevent
future non-compliance with&nbsp;Nasdaq&rsquo;s&nbsp;listing requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
can be no assurance that we will continue to meet the minimum bid price requirement, or any other requirement in the future. If
we fail to meet the minimum bid price requirement, or other applicable&nbsp;Nasdaq&nbsp;listing requirements, including maintaining
minimum levels of stockholders&rsquo; equity or market values of our common stock, our common stock could be delisted. Delisting
from&nbsp;Nasdaq&nbsp;would cause us to pursue eligibility for trading of our common stock on other markets or exchanges, or on
an over-the-counter market. In such case, our stockholders&rsquo; ability to trade or obtain quotations of the market value of
our common stock would be severely limited because of lower trading volumes and transaction delays. These factors could contribute
to lower prices and larger spreads in the bid and ask prices of these securities. There can be no assurance that our common stock,
if delisted from the&nbsp;Nasdaq, would be listed on a national securities exchange, a national quotation service or the over-the-counter
markets. Delisting from the&nbsp;Nasdaq&nbsp;could also result in negative publicity, make it more difficult for us to raise additional
capital, adversely affect the market liquidity of our common stock, decrease securities analysts&rsquo; coverage of us or diminish
investor, supplier and employee confidence. In addition, our stock could become a &ldquo;penny stock,&rdquo; which would make
trading of our common stock more difficult.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
stock price has been subject to fluctuations in the past, has recently been volatile, and will likely continue to be subject to
fluctuations and decline, due to factors beyond our control, and investors in our common stock may lose all or part of their&nbsp;investment
in our company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prior
to the public offering of our stock in June 2017, there was no market for shares of our common stock. Shares of our common stock
were sold in our June 2017 public offering at a price of $100.00&nbsp;per share and in our December 2019 public offering at a
price of $3.00 per share. Although our common stock is listed on the Nasdaq Capital Market, the market price of our common stock
may be subject to wide fluctuations in response to various factors, some of which are beyond our control, including, but not limited
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic and market
    conditions or trends in our industry or the economy as a whole and, in particular, in the construction industry;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions or departures
    of key personnel;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating results
    that fall below expectations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">industry developments;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new laws or regulations
    or new interpretations of existing laws or regulations applicable to our business;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">material litigation
    or government disputes;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the public&rsquo;s
    response to press releases or other public announcements by us or third parties, including our filings with the SEC;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in financial
    estimates or recommendations by any securities analysts who follow our common stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the size of our
    market float and potential dilution due to the exercise of outstanding options and warrants;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">future sales of
    our common stock by our officers, directors and significant stockholders,&nbsp;including sales pursuant to a registration
    statement filed to permit a significant stockholder to sell shares of our common stock, pursuant to certain registration rights
    granted to such stockholder;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other events or
    factors, including those resulting from such events, or the prospect of such events, including war, terrorism and other international
    conflicts, public health issues including health epidemics or pandemics, such as the recent outbreak of the COVID-19 novel
    coronavirus, and natural disasters such as fire, hurricanes, earthquakes, tornados or other adverse weather and climate conditions,
    whether occurring in the United States or elsewhere, could disrupt our operations, disrupt the operations of our suppliers
    or result in political or economic instability; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">period-to-period
    fluctuations in our financial results.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the securities markets have, from time to time, experienced significant price and volume&nbsp;fluctuations that are
unrelated to the operating performance of particular companies. These market fluctuations may also materially and adversely affect
the market price of our common stock. Since the stock price of our common stock has fluctuated in the past, has recently been
volatile and will likely be volatile in the future, investors in our common stock may lose all or part of their investment in
our company. In the past, stockholders have instituted securities class action litigation following periods of market volatility.
If we were to become involved in securities litigation, we could incur substantial costs and our resources and the attention of
management could be diverted from our business.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
trading in our stock has in the past and may continue to be very volatile.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
stock price and the trading volume of our stock continue to be very volatile. As such, investors may find it difficult to obtain
accurate stock price quotations and holders of our stock may be unable to resell their stock at desirable prices. Sales of substantial
amounts of our common stock, or the perception that such sales might occur, could adversely affect prevailing market prices of
our common stock and our stock price may decline substantially in a short period of time. As a result, our stockholders could
suffer losses or be unable to liquidate holdings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Sales
of a substantial number of shares of our common stock in the public market, or the perception that they might occur, could cause
the price of our common stock to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
price of our common stock could decline if there are substantial sales of our common stock, particularly sales by our directors,
executive officers and significant stockholders. If our existing stockholders sell substantial amounts of our common stock in
the public market, or if the public perceives that such sales could occur, this could have an adverse impact on the market price
of our common stock, even if there is no relationship between such sales and the performance of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to certain registration rights, we filed a registration statement in&nbsp;2018&nbsp;to permit a significant stockholder to sell
its shares of our common stock; we expect that, because there were a large number of shares registered pursuant to such registration
statement, the selling stockholder will continue to offer shares covered by such registration statement for a significant period
of time, the precise duration of which cannot be predicted, Accordingly, any adverse market or price pressures resulting from
sales by the significant stockholder may continue for an extended period of time and cause continued negative pressure on the
market price of our common stock, which could have a material adverse effect on our ability to raise additional equity capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, shares subject to outstanding options under our SG Blocks, Inc. Stock Incentive Plan (the &ldquo;Incentive Plan&rdquo;)
will become eligible for sale in the public market in the future, subject to certain legal and contractual limitations. Substantial
sales of such shares, at that time, could depress the sale price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Significant
sales of our common stock, or the possibility that these sales may occur, might make it more difficult for us to sell equity securities
in the future at a time and at a price that we deem appropriate. In addition, we may issue shares of our common stock in connection
with investments or acquisitions in the future. The amount of shares of our common stock issued in connection with an investment
or acquisition could constitute a material portion of our then-outstanding shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
principal stockholders and management own a significant percentage of our stock and will be able to exert significant control
over matters subject to stockholder approval. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of May 1, 2020, our directors and executive&nbsp;officers beneficially own approximately 4.0% of our outstanding common stock&nbsp;and
three of our stockholders&nbsp;beneficially owns approximately 8.9%, 7.5% and 7.2 %, respectively, of our outstanding common stock.
Accordingly, these stockholders will continue to have significant influence over the outcome of corporate actions requiring stockholder
approval, including the election of directors, merger, consolidation, or sale of all or substantially all of our assets, or any
other significant corporate transaction. The interests of these stockholders may not be the same as, or may even conflict with,
investors&rsquo; interests. For example, these stockholders could delay or prevent a change in control of us, even if such a change
in control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for
their common stock as part of a sale of us or our assets and might affect the prevailing price of our common stock. The significant
concentration of stock ownership may negatively impact the price of our common stock due to investors&rsquo; perception that conflicts
of interest may exist or arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
issuance of additional securities by our Board of Directors (the &ldquo;Board&rdquo; or &ldquo;Board of Directors&rdquo;) will
dilute the ownership interests of our current stockholders and could discourage the acquisition of us.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board, without any action by our stockholders, is authorized to designate and issue additional classes or series of capital stock
(including classes or series of preferred stock) as it deems appropriate and to establish the rights, preferences and privileges
of such classes or series, and&nbsp;we currently have an effective universal shelf registration statement on file with the SEC,
providing for the potential issuance of shares of our common stock and other securities.&nbsp;The issuance of any new class or
series of capital stock would not only dilute the ownership interest of our current stockholders but may also adversely affect
the voting power and other rights of holders of common stock.&nbsp;The rights of holders of preferred stock and other classes
of common stock that may be issued may be superior to the rights of the holders of the existing class of common stock in terms
of the payment of ordinary and liquidating dividends and voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the ability of the Board to designate and issue such shares could impede or deter an unsolicited tender offer or takeover
proposal regarding us and the issuance of additional shares having preferential rights could adversely affect the voting power
and other rights of holders of common stock and render more difficult the removal of current management, even if such removal
may be in the stockholders&rsquo; best interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
do not expect to pay dividends in the future. Any return on investment may be limited to the value of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the foreseeable future, we intend to retain any earnings to finance the development and expansion of our business, and we do not
anticipate paying any cash dividends on our common stock. Any determination to pay dividends in the future will be at the discretion
of our Board of Directors and will depend upon results of operations, financial condition, restrictions imposed by applicable
law and other factors our Board of Directors deem relevant. Accordingly, if you purchase shares of our common stock, realization
of a gain on your investment will depend on the appreciation of the price of our common stock, which may never occur. Investors
seeking cash dividends in the foreseeable future should not purchase our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
securities or industry analysts do not publish research or reports about our business or our industry, or publish negative reports
about our business or our industry, our stock price and trading volume could decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
trading market for our common stock will be influenced by the research and reports that securities or industry analysts publish
about us, our business, our industry or our competitors. If one or more of the analysts who cover us change their recommendation
regarding our stock adversely, change their opinion of the prospects for our company in a negative manner or provide more favorable
relative recommendations about our competitors, our stock price would likely decline. If one or more of these analysts cease coverage
of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause
our stock price or trading volume to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Certain
provisions of Delaware law could discourage, delay or prevent a merger or acquisition at a premium price.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
provisions of Delaware law could discourage potential acquisition proposals, delay or prevent a change in control of our company,
or limit the price that investors may be willing to pay in the future for shares of our common stock. Because we are incorporated
in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which prohibits a person
who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after
the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or
combination is approved in a prescribed manner. Such provisions may discourage, delay or prevent a merger or acquisition of the
Company, including a transaction in which the acquirer may offer a premium price for our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
our shares become subject to the penny stock rules, it would become more difficult to trade our shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are
generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges
or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect
to transactions in such securities is provided by the exchange or system. If we do not retain a listing on the&nbsp;Nasdaq&nbsp;Capital
Market and if the price of our shares of common stock is less than $5.00, our common stock will be deemed a penny stock (meaning
that our shares may be considered highly speculative and may trade infrequently, which can make them difficult to accurately price
or sell). The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those
rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules
require that, before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make
a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i) the purchaser&rsquo;s
written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny
stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect
of reducing the trading activity in the secondary market for our common stock, and therefore stockholders may have difficulty
selling their shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>As
a &ldquo;smaller reporting company,&rdquo; we may avail ourselves of reduced disclosure requirements, which may make our common
stock less attractive to investors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a &ldquo;smaller reporting company&rdquo; under applicable SEC rules and regulations, and, as a result of the&nbsp;SEC&rsquo;s&nbsp;recent
amendment to the definition of &ldquo;smaller reporting company,&rdquo; we will continue to be a &ldquo;smaller reporting company&rdquo;
for so long as either (i) the market value of our common stock held by non-affiliates as of the end of our most recently completed
second quarter (&ldquo;public float&rdquo;) is less than $250&nbsp;million or (ii) annual revenues of less than $100&nbsp;million
during the most recently completed fiscal year and (A) no public float or (B) a public float of less than $700&nbsp;million. As
a &ldquo;smaller reporting company,&rdquo; we have relied on exemptions from certain SEC disclosure requirements that are applicable
to other public companies. These exemptions include reduced financial disclosure and reduced disclosure obligations regarding
executive compensation. Until such time as we cease to be a &ldquo;smaller reporting company,&rdquo; such reduced disclosure in
our SEC filings may make it harder for investors to analyze our operating results and financial prospects. If some investors find
our common stock less attractive as a result of our reduced disclosure, there may be a less active trading market for our common
stock and our stock price may be more volatile.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
shares of common stock are from time to time thinly traded, so stockholders may be unable to sell at or near ask prices or at
all if they need to sell shares to raise money or otherwise desire to liquidate their shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
common stock has from time to time been &ldquo;thinly-traded,&rdquo; meaning that the number of persons interested in purchasing
our common stock at or near ask prices at any given time may be relatively small or non-existent. This situation is attributable
to a number of factors, including the fact that we are a small company that is relatively unknown to stock analysts, stock brokers,
institutional investors and others in the investment community that generate or influence sales volume, and that even if we came
to the attention of such persons, they tend to be risk-averse and would be reluctant to follow an unproven company such as ours
or purchase or recommend the purchase of our shares until such time as we became more seasoned and viable. As a consequence, there
may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned
issuer that has a large and steady volume of trading activity that will generally support continuous sales without an adverse
effect on share price. We cannot give stockholders any assurance that a broader or more active public trading market for our common
stock will develop or be sustained, or that current trading levels will be sustained.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_005"></A>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus and the documents incorporated by reference herein contain forward-looking statements, including statements regarding
the progress and timing of our product development, the goals of our development activities, estimates of the potential markets
for our product candidates, estimates of the capacity of manufacturing and other facilities to support our products, our expected
future revenues, operations and expenditures and projected cash needs. The forward-looking statements are contained principally
in the sections of this prospectus entitled &ldquo;Prospectus Summary&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Business&rdquo; and in the documents
incorporated by reference. These statements relate to future events of our financial performance and involve known and unknown
risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to
differ materially from those expressed or implied by these forward-looking statements. Those risks and uncertainties include,
among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic,
    political and financial conditions, both in the United States and internationally;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to obtain
    additional financing on acceptable terms, if at all, or to obtain additional capital in other ways;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to increase
    sales, generate income, effectively manage our growth and realize our backlog;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition in the
    markets in which we operate, including the consolidation of our industry, our ability to expand into and compete in new geographic
    markets and our ability to compete by protecting our proprietary manufacturing process;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a disruption or
    cybersecurity&nbsp;breach in our or third-party suppliers&rsquo; information technology systems;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to adapt
    our products and services to industry standards and consumer preferences&nbsp;and obtain general market acceptance&nbsp;of
    our products;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product shortages
    and the availability&nbsp;of raw materials, and potential loss of relationships with key vendors, suppliers or subcontractors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the seasonality
    of the construction industry in general, and the commercial and residential construction markets in particular;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a disruption or
    limited availability with our third-party transportation vendors;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the loss or potential
    loss of any significant&nbsp;customers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exposure to product
    liability, including the possibility our liability for estimated warranties may be inadequate, and various other claims and
    litigation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to attract
    and retain key employees;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to attract
    private investment for sales of product, the credit risk from our customers and our customers&rsquo; ability to obtaining
    third-party financing if and as needed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an impairment of
    goodwill;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of federal,
    state and local regulations, including changes to international trade and tariff policies, and the impact of any failure of
    any person acting on our behalf to comply with applicable regulations&nbsp;and guidelines;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs incurred relating
    to&nbsp;current and future legal proceedings or investigations;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the cost of compliance
    with environmental, health and safety laws and other local building regulations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to utilize
    our net operating loss carryforwards&nbsp;and the impact of changes in the United States&rsquo; tax rules and regulations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dangers inherent in our operations, such as
    natural or man-made disruptions to our facilities and project sites, and the adequacy of our insurance coverage;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to comply
    with the requirements of being a public company, including Nasdaq Capital Market listing requirements;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations in
    the price of our common stock, including decreases in price due to sales of significant amounts of stock;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential dilution
    of the ownership of our current stockholders due to, among other things, public offerings or private placements by the Company
    or issuances upon the exercise of outstanding options or warrants and the vesting of restricted stock units;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability of our
    principal stockholders, management and directors to potentially exert control due to their ownership interest;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any ability to pay
    dividends in the future;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential negative
    reports by securities or industry analysts&nbsp;regarding our business or the construction industry in general;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware law provisions
    discouraging, delaying or preventing a merger or acquisition at a premium price;&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to remain
    listed on the Nasdaq&nbsp;Capital Market and the possibility that our stock will be subject to penny stock rules;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other events or
    factors, including those resulting from such events, or the prospect of such events, including war, terrorism and other international
    conflicts, public health issues including health epidemics or pandemics, such as the recent outbreak of the recent outbreak
    of novel coronavirus (COVID-19), and natural disasters such as fire, hurricanes, earthquakes, tornados or other adverse weather
    and climate conditions, whether occurring in the United States or elsewhere, could disrupt our operations, disrupt the operations
    of our suppliers or result in political or economic instability; and</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our classification
    as a&nbsp;smaller reporting company resulting in, among other things, a potential reduction in active trading of our common
    stock or increased volatility in our stock price.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate
and, therefore, there can be no assurance that the forward-looking statements included in this prospectus will prove to be accurate.
In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information
should not be regarded as a representation by us or any other person that the objectives and plans of ours will be achieved. Readers
are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date on which such statements
are made. Any forward-looking statements made by us or on our behalf speak only as of the date they are made, and we do not undertake
to update any forward-looking statement that may be made from time to time on our behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_006"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">We
estimate that the net proceeds of this offering will be approximately $13.475 million, based on the public offering price of $2.50
per share of common stock, or approximately $15.567 million if the underwriters exercise in full their option to purchase additional
shares of common stock, and after deducting the estimated underwriting discount and estimated offering expenses payable by us.
The public offering price per common share was determined between us, the underwriter and investors based on market conditions
at the time of pricing and was at a discount to the current market price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Except
where indicated, the foregoing discussion assumes no exercise of the underwriters&rsquo; option to purchase up to 900,000 additional
shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to use the net proceeds from this offering primarily for working capital and general corporate purposes and engaging in
acquisitions or other business combinations or investments, sales and marketing activities, general and administrative matters
and capital expenditures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
amounts and timing of our actual expenditures will depend on numerous factors, including our business operations, as well as the
amount of cash used in our operations. We therefore cannot estimate with certainty the amount of net proceeds to be used for the
purposes described above. We may find it necessary or advisable to use the net proceeds for other purposes, and we will have broad
discretion in the application of the net proceeds. Pending the uses described above, we plan to invest the net proceeds from this
offering in short-term, investment-grade, interest-bearing securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_007"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth our capitalization as of December 31, 2019:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma basis
    to give effect to the issuance of 440,000 shares of our common stock in the April 2020 Offering and the receipt of net proceeds
    of approximately $1,500,000 and the addition of 12,672 shares of common stock upon the vesting of restricted stock units subsequent
    to December 31, 2019; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma as
    adjusted basis to give effect to the sale of 6,000,000 shares of common stock in this offering at the public offering price
    of $2.50 per share, after deducting underwriting discounts and commissions and other estimated offering expenses payable by
    us.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
capitalization table should be read in conjunction with &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations&rdquo; and our historical financial statements and notes to those financial statements that are incorporated
by reference in this prospectus.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma As Adjusted</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt; text-align: left">Cash and cash Equivalents</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">1,625,671</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">3,134,871</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">16,609,871</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Common stock, $0.01 par value, 25,000,000 shares authorized; 1,157,890&nbsp;issued and outstanding as of December 31, 2019; Preferred Stock, $1.00 par value, 5,405,010 shares authorized, no shares issued and outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">11,579</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">16,105</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">76,105</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Additional paid-in capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">21,932,387</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">23,437,061</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">36,852,061</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Accumulated deficit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(17,583,817</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(17,583,817</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(17,583,817</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Total stockholders&rsquo; equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,360,149</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,869,349</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">19,344,349</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt">Total liabilities and stockholder&rsquo;s equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">6,634,611</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">8,143,811</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">21,618,811</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unless
we indicate otherwise, all information in this Capitalization section:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no exercise by the underwriters of their over-allotment option;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no <FONT STYLE="background-color: white">exercise of the representative&rsquo;s warrants to be issued to the representative
    of the underwriters in this offering;</FONT></FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    53,190 shares of our common stock issuable upon the exercise of outstanding warrants with a weighted average exercise price
    of $35.14;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 53,170
    shares of our common stock issuable upon the exercise of outstanding options with a weighted average exercise price of $81.20;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes 9,187 restricted
    stock units (vested and unvested) granted under our SG Blocks, Inc. Stock Incentive Plan. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_008"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you purchase shares of our common stock in this offering, your ownership interest will be diluted to the extent of the difference
between the public offering price per share and the as adjusted net tangible book value per share after giving effect to this
offering. We calculate net tangible book value per share by dividing the net tangible book value, which is tangible assets less
total liabilities, by the number of outstanding shares of our common stock. Dilution in net tangible book value per share represents
the difference between the portion of the amount per share paid by purchasers of shares in this offering and the as adjusted net
tangible book value per share of our common stock immediately after giving effect to this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
pro forma net tangible book value as of December 31, 2019, was $2,347,024 or approximately $1.46 per share. Pro forma net tangible
book value per share represents the amount of our total tangible assets as adjusted to take into account cash proceeds of approximately
$1.5 million from the issuance of 440,000 shares of our common stock in the April 2020 Offering and the addition of 12,672 shares
of common stock upon the vesting of restricted stock units subsequent to December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">After
giving effect to the sale by us of 6,000,000&nbsp;shares of our common stock in this offering at the public offering price of
$2.50 per share, after deducting the estimated underwriting discount and estimated offering expenses payable by us, our as adjusted
net tangible book value as of December 31, 2019 would have been approximately $15.82 million, or approximately $2.08 per share.
This represents an immediate increase in as adjusted net tangible book value of $.62 per share to existing stockholders and an
immediate dilution of $.42 per share to new investors purchasing common stock in this offering. The following table illustrates
this per share dilution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 76%; padding-left: 9pt; text-indent: -9pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price per share </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 9%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50 </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 1%; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    forma net tangible book value per share as of December 31, 2019 </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in pro forma net tangible value per share attributable to new investors </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.62</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    adjusted pro form net tangible book value per share as of December 31, 2019, after giving effect to this offering </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.08</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
    per share to new investors purchasing shares in this offering </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$ </FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: right; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.42</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
foregoing discussion and table do not take into account further dilution to new investors that could occur upon the exercise of
outstanding options or warrants. In addition, we may choose to raise additional capital due to market conditions or strategic
considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional
capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in
further dilution to our stockholders.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_009"></A>MARKET
FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
common stock has traded on The Nasdaq Capital Market under the symbol &ldquo;SGBX&rdquo; since June 22, 2017. Prior to that time,
there was no public market for our common stock. As of May 1, 2020, there were approximately 82 stockholders of record of our
common stock. This number does not include beneficial owners from whom shares are held by nominees in street name. Accordingly,
the number of beneficial owners of our common stock exceeds this number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_010"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have never declared or paid any cash dividends on our common stock and we do not currently intend to pay any cash dividends on
our common stock in the foreseeable future. We expect to retain all available funds and future earnings, if any, to fund the development
and growth of our business. Any future determination to pay dividends, if any, on our common stock will be at the discretion of
our board of directors and will depend on, among other factors, our results of operations, financial condition, capital requirements
and contractual restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_011"></A>DESCRIPTION
OF OUR SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following summary description of our securities is based on the applicable provisions of the General Corporation Law of the State
of Delaware (the &ldquo;DGCL&rdquo;), and on the provisions of our Amended and Restated Certificate of Incorporation, as amended
(the &ldquo;Certificate of Incorporation&rdquo;) and our Amended and Restated Bylaws (the &ldquo;Bylaws&rdquo;), and is qualified
entirely by reference to the applicable provisions of the DGCL and copies of our Certificate of Incorporation and our Bylaws that
are filed as exhibits to the registration statement of which this prospectus forms a part. For further information on how to obtain
copies of such documents, please refer to the heading &ldquo;Where You Can Find More Information&rdquo; in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we are authorized by our Certificate of Incorporation to issue an aggregate of (i) 25,000,000
shares of common stock, par value $0.01 per share, and (ii) 5,405,010 shares of preferred stock, par value $1.00 per share. As
of the date of this prospectus, there were 1,610,524 shares of common stock issued and outstanding and zero shares of preferred
stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Voting.&nbsp;&nbsp;</I>Holders
of our common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders,
including the election of directors, and do not have cumulative voting rights. Our directors are elected by a plurality of the
votes cast by the stockholders entitled to vote at our annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Dividends.&nbsp;&nbsp;</I>Subject
to the prior rights of any class or series of preferred stock which may from time to time be outstanding, if any, holders of our
common stock are entitled to receive dividends ratably when, as and if declared by our Board of Directors, out of funds legally
available for that purpose. We have not paid any dividends on our common stock and none are contemplated in the foreseeable future.
We anticipate that all earnings that may be generated from our operations will be used to finance our growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Liquidation</I>.
Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets remaining
after payment of liabilities and payment of accrued dividends and liquidation preferences on the preferred stock, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Rights
and Preferences.</I>&nbsp; The holders of our common stock have no preemptive, subscription or redemption rights pertaining to
our common stock and have no rights to convert their common stock into any other securities. The absence of preemptive rights
could result in a dilution of the interest of the existing stockholders should additional shares of our common stock be issued.
In addition, the rights of holders of our common stock are subject to, and may be adversely affected by, the rights of holders
of shares of any series of preferred stock that we may designate and issue in the future. &nbsp;See &ldquo;Risk Factors&rdquo;
section in the Form 10-K for a further description of risks related to our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Fully
Paid and Nonassessable</I>.&nbsp; All of our issued and outstanding shares of common stock are fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No
shares of preferred stock are currently outstanding. Our Board of Directors has the authority, without further action by our stockholders,
to designate and issue up to 5,405,010 shares of preferred stock in one or more series, and to fix for each series voting rights,
if any, designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations
or restrictions as provided in a resolution or resolutions adopted by our Board of Directors. Prior to the issuance of shares
of each series, our Board of Directors is required by the DGCL and our Amended and Restated Certificate of Incorporation to adopt
resolutions and file a certificate of designation with the Secretary of State of the State of Delaware. The certificate of designation
fixes for each class or series the designations, powers, preferences, rights, qualifications, limitations and restrictions, which
includes one or more of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares
    constituting each class or series;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rights and terms,
    including prices, of redemption, including sinking fund provisions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dividend rights
    and rates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dissolution;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">terms concerning
    the distribution of assets;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">conversion or exchange
    terms;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preemption rights;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any restrictions
    on repurchase or redemption of the shares by the Company; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">liquidation preferences.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Satisfaction
of any dividend preferences of outstanding preferred stock would reduce the amount of funds available for the payment of dividends,
if any, on the common stock. Also, holders of the preferred stock would normally be entitled to receive a preference payment in
the event of any liquidation, dissolution or winding up of the Company before any payment is made to the holders of common stock.
In addition, under certain circumstances, the issuance of preferred stock may render more difficult or tend to discourage a merger,
tender offer or proxy contest, the assumption of control by a holder of a large block of the Company&rsquo;s securities or the
removal of incumbent management. The Board of Directors, without stockholder approval, may issue preferred stock with voting and
conversion rights, which could adversely affect the holders of common stock. As a result of these or other factors, the issuance
of preferred stock could have an adverse impact on the market price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Anti-Takeover
Effects of Delaware Law and Our Certificate of Incorporation and Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
provisions of Delaware law, our Certificate of Incorporation and our Bylaws contain provisions that could have the effect of delaying,
deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, are expected
to discourage certain types of coercive takeover practices and inadequate takeover bids. These provisions are also designed, in
part, to encourage persons seeking to acquire control of us to first negotiate with our Board of Directors. We believe that the
benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the
disadvantages of discouraging such proposals, including proposals that are priced above the then-current market value of our common
stock, because, among other reasons, such negotiation could result in an improvement of the terms of such proposals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Certificate
of Incorporation and Bylaws</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain
provisions set forth in our Certificate of Incorporation, our Bylaws and in Delaware law, which are summarized below, may be deemed
to have an anti-takeover effect and may delay, deter or prevent a tender offer or takeover attempt that a stockholder might consider
to be in its best interests, including attempts that might result in a premium being paid over the market price for the shares
held by stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Proposals
of business and nominations</I>. Our Bylaws generally regulate proposals of business and nominations for election of directors
by stockholders. In general, Section 3.16 requires stockholders intending to submit proposals or nominations at a stockholders
meeting to provide the Company with advance notice thereof, including information regarding the stockholder proposing the business
or nomination as well as information regarding the proposed business or nominee. Section 3.16 provides a time period during which
business or nominations must be provided to the Company that will create a predictable window for the submission of such notices,
eliminating the risk that the Company finds a meeting will be contested after printing its proxy materials for an uncontested
election and providing the Company with a reasonable opportunity to respond to nominations and proposals by stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Blank
Check Preferred Stock</I>. Our Board of Directors has the right to issue preferred stock in one or more series and to determine
the designations, rights, preferences of such preferred stock without stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Board
Vacancies</I>. Our Bylaws generally provide that only the board of directors (and not the stockholders) may fill vacancies and
newly created directorships.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
the foregoing provisions of our Certificate of Incorporation, Bylaws and Delaware law may have an anti-takeover effect, these
provisions are intended to enhance the likelihood of continuity and stability in the composition of the Board of Directors and
in the policies formulated by the Board of Directors and to discourage certain types of transactions that may involve an actual
or threatened change of control. In that regard, these provisions are designed to reduce our vulnerability to an unsolicited acquisition
proposal. The provisions also are intended to discourage certain tactics that may be used in proxy fights. However, such provisions
could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit
fluctuations in the market price of our common stock that could result from actual or rumored takeover attempts. Such provisions
also may have the effect of preventing changes in our management.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Delaware
Anti-Takeover Statute</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to the provisions of Section 203 of the DGCL (&ldquo;Section 203&rdquo;) regulating corporate takeovers. In general,
Section 203 prohibits a publicly-held Delaware corporation from engaging, under certain circumstances, in a business combination
with an interested stockholder for a period of three years following the date the person became an interested stockholder unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prior to the date
    of the transaction, the board of directors of the corporation approved either the business combination or the transaction
    which resulted in the stockholder becoming an interested stockholder;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon completion
    of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at
    least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes
    of determining the voting stock outstanding, the outstanding voting stock owned by the interested stockholder, (1) shares
    owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants
    do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or
    exchange offer; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at or subsequent
    to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized
    at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of
    the outstanding voting stock which is not owned by the interested stockholder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Generally,
a business combination includes a merger, asset, stock sale or other transaction resulting in a financial benefit to the interested
stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior
to the determination of interested stockholder status, did own 15% or more of a corporation&rsquo;s outstanding voting stock.
We expect the existence of Section 203 to have an anti-takeover effect with respect to transactions our Board of Directors does
not approve in advance. We also anticipate that Section 203 may discourage business combinations or other attempts that might
result in a premium over the market price for the shares of common stock held by our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Outstanding
Warrants </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
conjunction with the public offering that we consummated in June 2017, we issued to certain affiliates of the underwriters, as
compensation, warrants to purchase an aggregate of 4,313 shares of common stock at an exercise price of $125 per share. The warrants
are exercisable at the option of the holder on or after June 21, 2018 and expire June 21, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
conjunction with the offering that we consummated in April 2019, we also sold to investors warrants to purchase up to an aggregate
of 42,388 shares of common stock at an initial exercise price of $27.50 per share. The warrants are exercisable at the option
of the holder on or after October 29, 2019 and expire October 29, 2024. We also issued to certain affiliates of the underwriters,
as compensation, warrants to purchase an aggregate of 4,239 shares of common stock at an initial exercise price of $27.50 per
share. The warrants are exercisable at the option of the holder on or after October 29, 2019 and expire April 24, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
conjunction with the offering that we consummated in August 2019, we issued to the underwriter, as compensation, warrants to purchase
an aggregate of 2,250 shares of common stock at an initial exercise price of $21.25 per share. The warrants are exercisable at
the option of the holder on or after February 1, 2020 and expire August 29, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Options
and RSUs </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 26, 2016, the Board of Directors approved the issuance of up to 25,000 shares of our common stock in the form of restricted
stock or options (&ldquo;2016 Stock Plan&rdquo;). Effective January 20, 2017, the 2016 Stock Plan was amended and restated as
the SG Blocks, Inc. Stock Incentive Plan, as further amended effective June 1, 2018 (the &ldquo;Incentive Plan&rdquo;). The Incentive
Plan authorizes the issuance of up to 125,000 shares of common stock. As of December 31, 2019, there were 47,331 shares of common
stock available for issuance under the Incentive Plan and outstanding options to purchase 53,170 shares of common stock at a weighted
average exercise price per share of $81.20. We have also granted restricted stock units under the Incentive Plan of which 8,938
are non-vested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Listing
of Common Stock on the Nasdaq Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
common stock is currently listed on the Nasdaq Capital Market under the trading symbol &ldquo;SGBX.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
transfer agent and registrar for our common stock is American Stock Transfer and Trust Company, LLC. The transfer agent&rsquo;s
principal business address is 6201 15<SUP>th</SUP> Avenue, Brooklyn, New York 11219, and its telephone number is (800) 937-5449.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_012"></A>DESCRIPTION
OF SECURITIES WE ARE OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are offering 6,000,000 shares of our common stock, assuming no exercise of the over-allotment option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Common
Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
material terms and provisions of our common stock and each other class of our securities which qualifies or limits our common
stock are described under the caption &ldquo;Description of Our Securities&rdquo; in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Representative&rsquo;s
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Please
see &ldquo;Underwriting &mdash; Representative&rsquo;s Warrants&rdquo; in this prospectus for a description of the warrants we
have agreed to issue to the representative of the underwriters in this offering, subject to the completion of the offering. We
expect to enter into a warrant agreement in respect of the representative&rsquo;s warrants in connection with the closing of this
offering.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_013"></A>UNDERWRITING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have entered into an underwriting agreement, dated May 6, 2020, with ThinkEquity, a division of Fordham Financial Management,
Inc., acting as the sole book-running manager (sometimes referred to as the &ldquo;Representative&rdquo;). Subject to the terms
and conditions of the underwriting agreement, the underwriter named below has agreed to purchase, and we have agreed to sell to
it, the number of shares of common stock at the public offering price, less the underwriting discounts and commissions, as set
forth on the cover page of this prospectus and as indicated below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Underwriters</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> Shares of<BR> Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font-size: 10pt; text-align: justify; padding-bottom: 1.5pt">ThinkEquity, a division of Fordham Financial Management, Inc.</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,000,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: justify; padding-bottom: 4pt; padding-left: 9pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; font-weight: bold; text-align: right">6,000,000</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriting agreement provides that the obligations of the underwriter to pay for and accept delivery of the shares of common
stock offered by this prospectus are subject to various conditions and representations and warranties, including the approval
of certain legal matters by its counsel and other conditions specified in the underwriting agreement. The shares of common stock
are offered by the underwriter, subject to prior sale, when, as and if issued to and accepted by it. The underwriter reserves
the right to withdraw, cancel or modify the offer to the public and to reject orders in whole or in part. The underwriter is obligated
to take and pay for all of the shares of common stock offered by this prospectus if any such shares of common stock are taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have agreed to indemnify the underwriter and certain of its affiliates and controlling persons (within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act), among others, against specified liabilities, including liabilities
under the Securities Act, and to contribute to payments the underwriter may be required to make in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Discounts
and Commissions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriter proposes to offer the shares of common stock directly to the public at the public offering price set forth on the
cover page of this prospectus. <FONT STYLE="background-color: white">The underwriters have advised us that they propose to offer
the shares of common stock to the public at the public offering price set forth on the cover page of this prospectus and to certain
dealers at that price less a concession not in excess of $0.10 per share of common.</FONT> After the offering to the public, the
offering price and other selling terms may be changed by the underwriter without changing the proceeds we will receive from the
underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table summarizes the public offering price, underwriting commissions and proceeds before expenses to us. The underwriting
commissions are 7.0% of the public offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share of Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total Without <BR> Over-allotment <BR> Option</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total With <BR> Over-allotment <BR> Option</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-size: 10pt">Public offering price</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2.50</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">15,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">17,250,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Underwriting discount (7%)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.175</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,050,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,207,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Proceeds, before expenses, to us</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">2.325</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">13,950,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">16,042,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accountable expense allowance (1%)<SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.025</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">150,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">150,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The non-accountable
    expense allowance will not be payable with respect to any exercise by the representative of the over-allotment option.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
stated above, <FONT STYLE="background-color: white">we have agreed to pay a non-accountable expense allowance to the underwriter
equal to 1% of the gross proceeds received at the closing of the offering. </FONT>We have also agreed to pay certain of the Representative&rsquo;s
expenses relating to the offering, including the fees and expenses of the Representative&rsquo;s legal counsel and for the underwriter&rsquo;s
use of Ipreo&rsquo;s book-building, prospectus tracking and compliance software for this offering, totaling $113,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
total estimated expenses of the offering, including the non-accountable expense allowance, registration, filing and listing fees,
printing fees and legal and accounting expenses, but excluding underwriting discounts and commissions, are approximately $475,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Over-allotment
Option</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have granted a 45-day option to the Representative of the underwriters to purchase up to&nbsp;900,000&nbsp;additional shares of
common stock from us solely to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Representative&rsquo;s
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
closing of this offering, we have agreed to issue to the Representative as compensation warrants to purchase a number of shares
of common stock equal to 300,000 shares, which is 5% of the aggregate number of shares of common stock sold in this offering (excluding
the over-allotment option), or the Representative&rsquo;s Warrants. The Representative&rsquo;s Warrants will be exercisable at
a per share exercise price equal to $3.125, which is 125% of the public offering price per share in this offering. The Representative&rsquo;s
Warrants are exercisable at any time and from time to time, in whole or in part, during the four and one half year period commencing
180 days from the effective date of the registration statement of which this prospectus is a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Representative&rsquo;s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant
to Rule 5110(g)(1) of FINRA. The Representative (or permitted assignees under Rule 5110(g)(1)) will not sell, transfer, assign,
pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short
sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying
securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for
registration rights upon request, in certain cases. The one-time demand registration right provided will not be greater than five
years from the effective date of the registration statement in compliance with FINRA Rule 5110(f)(2)(G)(iv). The unlimited piggyback
registration right provided will not be greater than seven years from the effective date of the registration statement in compliance
with FINRA Rule 5110(f)(2)(G)(v). We will bear all fees and expenses attendant to registering the securities issuable on exercise
of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares
issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend or
our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not
be adjusted for issuances of shares of common stock at a price below the warrant exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Right
of First Refusal&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result of the December 2019 Offering (as hereinafter defined), beginning on May 11, 2020 and ending twelve (12) month&rsquo;s
thereafter, the representative has a right of first refusal to act as sole investment banker, sole book-runner and/or sole placement
agent, at its sole discretion, for each and every of our future public equity and debt offerings, including all equity linked
financings, for us, or any of our successors or subsidiaries, on terms customary to the Representative. The Representative in
conjunction with us, has the sole right to determine whether or not any other broker-dealer shall have the right to participate
in any such offering and the economic terms of any such participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Lock-Up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to &ldquo;lock-up&rdquo; agreements, we, our executive officers and directors, have agreed, without the prior written consent
of the Representative, not to, directly or indirectly, offer to sell, sell, pledge or otherwise transfer or dispose of any of
shares of (or enter into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition
by any person at any time in the future of) our common stock, enter into any swap or other derivatives transaction that transfers
to another, in whole or in part, any of the economic benefits or risks of ownership of shares of our common stock, make any demand
for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the
registration of any shares of common stock or securities convertible into or exercisable or exchangeable for common stock or any
other securities of ours or publicly disclose the intention to do any of the foregoing, subject to customary exceptions, for a
period of 90 days after the date of this prospectus for our directors and officers as well as the Company and any successor of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Other</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><I>Public
Offerings</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">On
April 3, 2020, we consummated the April 2020 Offering in which we issued and sold an aggregate of 440,000 shares of our common
stock at a public offering price of $4.25 per share. The net proceeds to us from the April 2020 Offering, after deducting the
underwriting discount, the underwriters&rsquo; fees and expenses and our estimated offering expenses, were approximately $1.6
million. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ThinkEquity acted as the representative of the underwriters
in <FONT STYLE="background-color: white">the April 2020 Offering and was paid (i) $149,600 in underwriting commissions (8% of
the public offering price) and (ii) </FONT>a non-accountable expense allowance equal to 1% (or $18,700) of the gross proceeds
received at the closing of the offering. We also paid certain of the representative&rsquo;s out-of-pocket expenses related to
the <FONT STYLE="background-color: white">April 2020 Offering</FONT>, including, but not limited to, <FONT STYLE="background-color: white">the
fees and expenses of the representative&rsquo;s legal counsel and for the underwriter&rsquo;s use of Ipreo&rsquo;s book-building,
prospectus tracking and compliance software for the offering, totaling $67,500.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">On
December 13, 2019, we consummated the December 2019 Offering in which we issued and sold an aggregate of 857,500 shares of our
common stock at a public offering price of $3.00 per share. The 857,500 shares of common stock issued and sold in the December
2019 Offering included 107,500 shares sold pursuant to the exercise in full by the underwriters of their over-allotment option.
The net proceeds to us from the December 2019 Offering, after deducting the underwriting discount, the underwriters&rsquo; fees
and expenses and our estimated offering expenses, were approximately $2.04 million. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ThinkEquity
acted as the representative of the underwriters in <FONT STYLE="background-color: white">the December 2019 Offering and was paid
(i) $205,800 in underwriting commissions (8% of the public offering price) and (ii) </FONT>a non-accountable expense allowance
equal to 1% (or $22,500) of the gross proceeds received at the closing of the offering. We also paid certain of the representative&rsquo;s
out-of-pocket expenses relating to the December 2019 Offering, including, but not limited to, the fees and expenses of the representative&rsquo;s
legal counsel, up to a maximum of $103,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><I>Private
Placement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">On
November 12, 2019, we entered into a Securities Purchase Agreement (the &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Purchase
Agreement<FONT STYLE="background-color: white">&rdquo;) with an investor, pursuant to which we issued to the investor a senior
secured convertible debenture in the principal amount of $480,770 (the &ldquo;</FONT>Debenture<FONT STYLE="background-color: white">&rdquo;)
for proceeds of $375,000 (representing an original issue discount of 22%). </FONT>In connection with the issuance of the Debenture,
we entered into a Placement Agency Agreement with ThinkEquity pursuant to which we paid cash fees to ThinkEquity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Subsequent
Equity Sales</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subject
to certain exceptions, until 90 days following the date hereof, neither we nor any of our subsidiaries may issue, enter into any
agreement to issue, effectuate or announce the issuance or proposed issuance of any shares of common stock or common stock equivalents
(or a combination of units thereof), including a variable rate transaction (as defined in the underwriting agreement) without
the Representative&rsquo;s consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Determination
of Offering Price</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
public offering price of the securities we are offering was negotiated between us and the underwriter based on the trading of
our common stock prior to the offering, among other things. Other factors considered in determining the public offering price
of the shares include the history and prospects of the Company, the stage of development of our business, our business plans for
the future and the extent to which they have been implemented, an assessment of our management, general conditions of the securities
markets at the time of the offering and such other factors as were deemed relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;SGBX.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price
Stabilization, Short Positions and Penalty Bids</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with this offering, the underwriter may engage in transactions that stabilize, maintain or otherwise affect the price
of our common stock. The underwriter may elect to stabilize the price of our common stock by bidding for, and purchasing, common
stock in the open market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
underwriter may also impose a penalty bid. This occurs when a particular underwriter or dealer repays selling concessions allowed
to it for distributing a security in this offering because the underwriter repurchases that security in stabilizing or short covering
transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finally,
the underwriter may bid for, and purchase, shares of our common stock in market making transactions, including &ldquo;passive&rdquo;
market making transactions as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">These
activities may stabilize or maintain the market price of our common stock at a price that is higher than the price that might
otherwise exist in the absence of these activities. The underwriter is not required to engage in these activities, and may discontinue
any of these activities at any time without notice. These transactions may be effected on the Nasdaq Capital Market, in the over-the-counter
market, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with this offering, the underwriter and selling group members, if any, or their affiliates may engage in passive market
making transactions in our common stock immediately prior to the commencement of sales in this offering, in accordance with Rule
103 of Regulation M under the Exchange Act. Rule 103 generally provides that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    passive market maker may not effect transactions or display bids for our common stock in excess of the highest independent
    bid price by persons who are not passive market makers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">net
    purchases by a passive market maker on each day are generally limited to 30% of the passive market maker&rsquo;s average daily
    trading volume in our common stock during a specified two-month prior period or 200 shares of common stock, whichever is greater,
    and must be discontinued when that limit is reached; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; padding-right: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">passive
    market making bids must be identified as such.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Electronic
Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
prospectus in electronic format may be made available on websites or through other online services maintained by one or more of
the underwriters, or by their affiliates. Other than this prospectus in electronic format, the information on any underwriter&rsquo;s
website and any information contained in any other website maintained by an underwriter is not part of this prospectus or the
registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or any underwriter in
its capacity as underwriter, and should not be relied upon by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_014"></A>NOTICE
TO INVESTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Notice
to Investors in the United Kingdom</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a &ldquo;Relevant
Member State&rdquo;) an offer to the public of any securities which are the subject of the offering contemplated by this prospectus
may not be made in that Relevant Member State except that an offer to the public in that Relevant Member State of any such securities
may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant
Member State:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to legal
    entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose
    corporate purpose is solely to invest in securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to any
    legal entity which has two or more of: (1) an average of at least 250 employees during the last financial year; (2) a total
    balance sheet of more than &euro; 43,000,000; and (3) an annual net turnover of more than &euro; 50,000,000, as shown in its
    last annual or consolidated accounts;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by the
    underwriter to fewer than 100 natural or legal persons (other than qualified investors as defined in the Prospectus Directive);
    or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in any
    other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of these securities
    shall result in a requirement for the publication by the issuer or the underwriter of a prospectus pursuant to Article 3 of
    the Prospectus Directive.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the purposes of this provision, the expression an &ldquo;offer to the public&rdquo; in relation to any of the securities in any
Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer
and any such securities to be offered so as to enable an investor to decide to purchase any such securities, as the same may be
varied in that Member State by any measure implementing the Prospectus Directive in that Member State and the expression &ldquo;Prospectus
Directive&rdquo; means Directive 2003/71/EC and includes any relevant implementing measure in each Relevant Member State.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
underwriter has represented, warranted and agreed that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it has
    only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement
    to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the &ldquo;FSMA&rdquo;))
    received by it in connection with the issue or sale of any of the securities in circumstances in which section 21(1) of the
    FSMA does not apply to the issuer; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it has
    complied with and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to
    the securities in, from or otherwise involving the United Kingdom.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>European
Economic Area</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
particular, this document does not constitute an approved prospectus in accordance with European Commission&rsquo;s Regulation
on Prospectuses no. 809/2004 and no such prospectus is to be prepared and approved in connection with this offering. Accordingly,
in relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (being the Directive
of the European Parliament and of the Council 2003/71/EC and including any relevant implementing measure in each Relevant Member
State) (each, a Relevant Member State), with effect from and including the date on which the Prospectus Directive is implemented
in that Relevant Member State (the Relevant Implementation Date) an offer of securities to the public may not be made in that
Relevant Member State prior to the publication of a prospectus in relation to such securities which has been approved by the competent
authority in that Relevant Member State or, where appropriate, approved in another Relevant Member State and notified to the competent
authority in that Relevant Member State, all in accordance with the Prospectus Directive, except that it may, with effect from
and including the Relevant Implementation Date, make an offer of securities to the public in that Relevant Member State at any
time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to legal entities
    which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate
    purpose is solely to invest in securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to any legal entity
    which has two or more of: (1) an average of at least 250 employees during the last financial year; (2) a total balance sheet
    of more than &euro; 43,000,000; and (3) an annual net turnover of more than &euro; 50,000,000, as shown in the last annual
    or consolidated accounts; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; width: 24px; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0; font-family: Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in any other circumstances
    which do not require the publication by the Issuer of a prospectus pursuant to Article 3 of the Prospectus Directive.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the purposes of this provision, the expression an &ldquo;offer of securities to the public&rdquo; in relation to any of the securities
in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the
offer and the securities to be offered so as to enable an investor to decide to purchase or subscribe for the securities, as the
same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State. For these purposes
the securities offered hereby are &ldquo;securities.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Canada</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
offering of our common stock in Canada is being made on a private placement basis in reliance on exemptions from the prospectus
requirements under the securities laws of each applicable Canadian province and territory where our common stock may be offered
and sold, and therein may only be made with investors that are purchasing, or deemed to be purchasing, as principal and that qualify
as both an &ldquo;accredited investor&rdquo; as such term is defined in National Instrument 45-106 <I>Prospectus Exemptions</I>
or subsection 73.3(1) of the <I>Securities Act</I> (Ontario) and as a &ldquo;permitted client&rdquo; as such term is defined in
National Instrument 31-103 <I>Registration Requirements, Exemptions and Ongoing Registrant Obligations.</I> Any offer and sale
of our common stock in any province or territory of Canada may only be made through a dealer that is properly registered under
the securities legislation of the applicable province or territory wherein our common stock is offered and/or sold or, alternatively,
where such registration is not required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
resale of our common stock by an investor resident in Canada must be made in accordance with applicable Canadian securities laws,
which require resales to be made in accordance with an exemption from, or in a transaction not subject to, prospectus requirements
under applicable Canadian securities laws. These resale restrictions may under certain circumstances apply to resales of the common
stock outside of Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this
prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages
are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province
or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province
or territory for particulars of these rights or consult with a legal advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section
3A.4) of National Instrument 33-105 <I>Underwriting Conflicts</I> (&ldquo;NI 33-105&rdquo;), the underwriters are not required
to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Upon
receipt of this prospectus, each Qu&eacute;bec investor hereby confirms that it has expressly requested that all documents evidencing
or relating in any way to the sale of the securities described herein (including for greater certainty any purchase confirmation
or any notice) be drawn up in the English language only. <I>Par la r&eacute;ception de ce document, chaque investisseur qu&eacute;becois
confirme par les pr&eacute;sentes qu&rsquo;il a express&eacute;ment exig&eacute; que tous les documents faisant foi ou se rapportant
de quelque mani&egrave;re que ce soit &agrave; la vente des valeurs mobili&egrave;res d&eacute;crites aux pr&eacute;sentes (incluant,
pour plus de certitude, toute confirmation d&rsquo;achat ou tout avis) soient r&eacute;dig&eacute;s en anglais seulement</I>.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Enforcement
of Legal Rights</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
of our directors and officers as well as the experts named herein may be located outside of Canada and, as a result, it may not
be possible for Canadian purchasers to effect service of process within Canada upon us or those persons. All or a substantial
portion of our assets and the assets of those persons may be located outside of Canada and, as a result, it may not be possible
to satisfy a judgment against us or those persons in Canada or to enforce a judgment obtained in Canadian courts against us or
those persons outside of Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Taxation
and Eligibility for Investment</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Canadian
purchasers of our shares of common stock should consult their own legal and tax advisors with respect to the tax consequences
of an investment in the share in their particular circumstances and about the eligibility of the shares for investment by the
purchaser under relevant Canadian legislation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_015"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
validity of the securities offered hereby will be passed upon for us by Gracin &amp; Marlow, LLP, New York, New York. Ellenoff
Grossman &amp; Schole LLP, New York, New York, is acting as counsel to the underwriters in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_016"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
consolidated financial statements </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">as of December 31, 2019 and
2018 and for each of the two years in the period ended December 31, 2019 are <FONT STYLE="background-color: white">incorporated
by reference in this prospectus to our Annual Report on Form 10-K for the year ended December 31, 2019 and have been so incorporated
in reliance upon such reports (which contains an explanatory paragraph relating to the Company&rsquo;s ability to continue as
a going concern as described in Note 2 to such financial statements) of Whitley Penn LLP, an independent registered public accounting
firm, given on the authority of such firm as experts in accounting and auditing.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_017"></A>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered by
this prospectus. This prospectus, which is part of the registration statement, omits certain information, exhibits, schedules
and undertakings set forth in the registration statement. For further information pertaining to us and the securities offered
hereby, reference is made to the registration statement and the exhibits and schedules to the registration statement. Statements
contained in this prospectus as to the contents or provisions of any documents referred to in this prospectus are not necessarily
complete, and in each instance where a copy of the document has been filed as an exhibit to the registration statement, reference
is made to the exhibit for a more complete description of the matters involved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Registration
statements and certain other filings made with the SEC electronically are publicly available through the SEC&rsquo;s website at
<I>www.sec.gov</I>. The registration statement, including all exhibits and amendments to the registration statement, has been
filed electronically with the SEC. You may also read all or any portion of the registration statement and certain other filings
made with the SEC on our website at <I>www.sgblocks.com</I>. The information contained in, and that can be accessed through, our
website is not incorporated into and is not part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are subject to the information and periodic reporting requirements of the Exchange Act and, accordingly, are required to file
annual reports containing financial statements audited by an independent public accounting firm, quarterly reports containing
unaudited financial data, current reports, proxy statements and other information with the SEC. You may obtain electronic copies
of such periodic reports, proxy statements and other information at the website of the SEC referred to above, and our website
at <I>www.sgblocks.com</I>. Except for the specific incorporated reports and documents listed above, no information available
on or through our website shall be deemed to be incorporated in this prospectus or the registration statement of which it forms
a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="a_018"></A>INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
SEC allows us to &ldquo;incorporate by reference&rdquo; certain information that we will file with it which means that we can
disclose important information to you by referring you to those documents instead of having to repeat the information in this
prospectus. The later information that we file with the SEC will automatically update and supersede this information. We incorporate
by reference the documents listed below and we also incorporate by reference into this prospectus all documents (other than current
reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) that
are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (Commission File No. 001-38037))
after the date of this prospectus but prior to the termination of the offering. These documents include periodic reports, such
as Annual Reports on Form 10-K, Quarterly Reports on Form&nbsp;10-Q and Current Reports on Form 8-K, as well as proxy statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following documents are incorporated by reference into this document:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; width: 0.25in; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; width: 0.25in; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our Annual Report on Form 10-K for the year ended December 31, 2019 (File No. 001-38037) filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020008003/sgbx-20191231.htm">March 30, 2020</A> and Annual Report on Form 10-K/A (Amendment No. 1) for the year ended December 31, 2019 (File No. 001-38037) filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020009211/f10k2019a1_sgblocksinc.htm">April 15, 2020</A>;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT> </TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    Current Reports on Form 8-K (File No. 001-38037) filed with the SEC <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020000052/f8k010220_sgblocks.htm">January
    2, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020001196/f8k011520_sgblocksinc.htm">January
    16, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020001584/f8k012120_sgblocksinc.htm">January
    23, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020002638/f8k020420_sgblocksinc.htm">February
    5, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020002724/f8k020420_sgblocksinc.htm">February
    6, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020004569/f8k022120_sgblocks.htm">February 24,
    2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020008555/ea120371-8k_sgblocks.htm">April 3, 2020</A>,
    <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020009208/ea120678-8k_sgblocksinc.htm">April 15</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020009394/ea120761-8k_sgblocksinc.htm">April
    17</A><A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020010253/ea121053-8k_sgblocks.htm">, April 28,
    2020,</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390020010944/ea121379-8k_sgblocksinc.htm">May 5, 2020</A>; and</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The description of our common stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1023994/000121390017002571/f8a12b0317_sgblocksinc.htm">Form 8-A</A> filed under the Exchange Act, as filed on March 20, 2017 (File No. 001-38037), including any amendment or report filed for the purpose of updating such description.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will provide to each person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the reports
or documents that we incorporate by reference in this prospectus contained in the registration statement (except exhibits to the
documents that are not specifically incorporated by reference) at no cost to you, by writing or calling us at the following address
and telephone number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SG
Blocks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>195
Montague Street, 14th Floor<BR>
Brooklyn, New York 11201</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(646)
240-4235</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Information
about us is available at our website at <I>www.sgblocks.com.</I> Except for the specific incorporated reports and documents listed
above, no information available on or through our website shall be deemed to be incorporated in this prospectus or the registration
statement of which it forms a part. Any statement contained in this registration statement or in a document incorporated or deemed
to be incorporated by reference in this registration statement shall be deemed to be modified or superseded for purposes of this
registration statement to the extent that a statement contained in this registration statement or in any other subsequently filed
document which also is or is deemed to be incorporated by reference in this registration statement modifies or supersedes that
statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part
of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>6,000,000
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="img_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ThinkEquity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>a
division of Fordham Financial Management, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>May
6, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Through
and including May 31, 2020 (25 days after commencement of this offering), all dealers that effect transactions in these securities,
whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealer&rsquo;s
obligation to deliver a prospectus when acting as an underwriter and with respect to their unsold allotments or subscriptions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !C &0# 2(  A$! Q$!_\0
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MH<,D@(=3[@UV^A^,+RP5 7^UVO'#-EE'L?Z&JGQ'U+3=6L=-O+,)YQE99,J
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IBMHEA@C2.*,!41!@*/0"BB@":BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,  B8# 2(  A$! Q$!_\0
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MC!XY[T+TIV/6A <YXUR/"5]R<G:/_'A7AGB/6+G0O'ZW=BH%SY:1+(PR(RP
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M2O(--2>>XA#JQ@))W$'C&:]-T.(N+QVB:)C<,2C=1[5Y)X%TZ;2O%,,TJ/,
MV3Y:GG!['O7I-UK-]8M<!%MK1))&827#Y8 ^@'.:YZK7-H:4H2:.P2+,9)(
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ML9[JY$D[:++:VZQEEEG(#,<9&!Z5R'C 8OIN.?[2BY_"O4KL[M';.2/*/?\
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MWKM;W-C), !C@8QFO2/#E@IT*QDBL(?,,*EIK@[F)]0.U<U7N=,+I6,S3+&
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MB58''.>E>->'T7^T8)[Z4F(E6?S3PIQDYKN?&7C[PS-I-YI::HKRRJ 6C!(
M!YY[]*\JU'QII4>F366GV+3O(@4W$YQC'0@4E"4F;TG%1=]QTD]E?_$>_EM@
MCPX/EX4%2>.@[UVEM&MCI=\VH2Q6L,D+*OFD+C+ X [\5Y/H*Z^+MYM'M)7G
MD&TR+'D 'T)Z5UT'PYUO59!-K^IE 3G8&,C<\G@<"MIQCI=A!MIV1@^,]5T^
M_DMX+&Y$ZPDEGQA23@ #UQ6!9:?=W\H6RLY9FZ$JA(_.O8K/P/X8T6,/=)"2
M.DEW(!D^R@YJPFMZ9$?)TVTGOB!C9:PE$_$D#(J7745:)2P\IN[/-;?P!JLK
M+]I*P%N B LQ'T'2NFM_A>ME:"[O$Q&.6>ZD"!0.^.]=%/J?BEED>WLH-,C5
M"W WN>/7M5"TT+^W&A&OZM<B>8A1%N+>:2,\ =!4^V<B_JZCJRM!-X0TZ/*W
M#7+G@0VL6,GZULQZQJ9MT.DZ#;V:D ++<$,_UQ7*2:(5U>\T[3[:2XDLVQD,
M%"YZ<UZ'X)LYA!<0.%5H2 S.2S D<@$]!]*F;?1E4Y170QO^$>U_6VSJVKW+
M1@9\N',:CVJ=O"FB00&*985E"$L6/F-C'4GM6W8B:_\ B#?Z?<W,CV=K;+*D
M8.!N)/)QUZ57T)$/A#6[LJK2O?2#<0"<!L8!]*Q?-NV.6(C>R1RFH6EO:^*3
M:QJ1%%I@V@CJ"1VKM-'UM]0L9IM+L5CM+,B*1Y3R6  X'IS7*:L2?'M\#SMT
M]!],D5N>"CCP5K3G.#>-T^HK2?PF4Y/H-T&XO_$0UB]O;Z18K*8K###\JGCJ
M?6IO!-O!=^*?$,T\:RM&8PAD&[;\H)QGI3/ G_(NZ])P2UTPS^%3_#_G6?$S
M#G]Z@!'^Z*32L2[LY#X@9_LO4B1C.H*,_05R/A2,/XOT5?6<''IBNL\??\@:
M](P0=0'\JYKP4OF>.-$4#(,A/3VK:G\!%1>\CVC4"3\0;,Y^5;1LC\:POB3@
M^&HE/>[C!/XUO71!^(*8_ALST/3FL'XE,J:!;LSA4%W&SL>@ QFN:&LC9+0Z
M+QS\GP\N1ZVRC]!3D^3X5(,@'[ ,?E6%X@\26OB#P)?26D<OV%8<+<.,!R!@
M@"LS0?$FH^(? UZ0(K6QL(/)V#EY"!U/I6C3L9<KT.MT9O+T#3U/7R5XJEXJ
MRWAG4,] !^/(J[HREM!T]B0285)S]*K>+1GPOJ ')(7^8K-7N="T5CG;<$?$
M.%>N-)C_ )"NS4$6XR1[5Q]N"/B,&[KI<0 _X"*[$C$48[YR35S9$3C_ !N"
MFBQ=R9&_#Y:Z3X?.D'@'36ED6--A)+D =3ZUS_C@G^R8 ,9WOC/^[7*_"D'7
M-1N[75'DN8((@8HV<A5Y]*:^"Y,EJ=#KVJ6&E_$[3]2O;I([5;<GS"<@]>GK
M75Q>)$UI-MK8W MF!87$B[5(P<$>N:\G^+JQ#6+>)%"I%;D*H' &>U>LZ42/
M!NF<G'V= !G_ &:4K<J8TKNQXD7">-;5\$ 2L?IS7M6I$'P],PQ\T+$?]\UX
MA<@CQ!&^2")6&<=,DU[7=\^$Y&QR+-CC\*TF[I!%69Y]X-&?%%AD<A2?T-0W
MY)^(%\ < WL8.>_-6?!\=RFIV>IM;L+=5P2[  ^A&:JSE!XHFOY9XTCGU&-8
MT#9)(/7Z4+5CL)\0,>5>>HOU'Z&M;X>+_P 4!,0.#/)T[#%9/C\$PWQ(SG4%
M(/M@UL_#X ?#N8DX'G2$8Z]*4O@L2[<YR'P\4_\ "?6@R 292#VJ]\5%QX@A
MSS^Y:J'P[<)X]M96!,:&0,V,@9Z9]*O_ !/62Y\16ZPHS;HRJX'&2>I-5_R\
M)LW%GH'A@ >!=,/&3;MC\C7G.FI8SZ1''=7;1$7$NY$4DL":[[1[R&P\+V5A
M<RQK-#;E2N<DDCH,?6N1L]0\,:6Q@O;B07"L3(@3 !)['O6<;W=C1)1BKDVN
MZC%>:;I]@L%S-")E&&&"RCIC\JP;^5+_ ,2::2H13<%=@.=H!&!GO6SJGB/P
MY)=::VGCS)(Y]Q1B>1@]3]:X^.]N-1\0->@0P1PS-(L8.!DGG %;QB[:D3:O
M9'O$3 Q)M.0!CFBN'B\8700'S(5XQT%%9.)6G<]I!QS2[LGO35P2 2<$]J\V
MU/Q#KT%]JDTNH7UM%;S$6XM+1)[;RQCF1N2#G.1D$5STX\^QS2:1Z7N]ORZ5
M4M=5MKVZOK:!F:2QD$4P(. Q4,,?@:XZWO->UW2=5UFU\0M9K:M(D4-O C1M
ML7()+ DYY/M69X3MM:UF77+^#Q#/8NYAE<1PHRO(85)9B0< ^@P,5LJ6FI//
M<]&M]3M[F_O+&%V,UFP$RD<#<,@>_%6L]1S7DGA_7-7UGQ!);PWJV%SJ;H;B
MXBC#']W'SM!R 3C/?@UKW&K:_9Z^?#/]LM-)+<P)'J#PJ)(U968C &TGY0 2
M.]$H/:X)I=#M]0U6UTP6QNF9?M,ZP1X&<L<XSZ#CK5W)'&#FO./%C:CHIT\:
MCJC:K#%?P31Q^6HN0<D$!5 !!XP<>M3/KVOZAHAU:VO#$;B\$+V5M$K36D:Y
MR K<M(2 2", =!WI.D^XN97/0<Y'(-&*Y3PCJEU=W>H6MS>WEP( CJ+ZV$,R
MY!SD  $<<$#KD5U61@<UC*\79FBLQ>!6?K]H]_H%Y:Q!2TD1 !Z'OBK^1]:9
M.VVWD.2,*2?RI*?8:6I\W^+K:_N]/L;UEAM(XV-LJ1GH1U)%<L;6]0[1<[@3
MZ=*[/Q1*1H5N"Q(DOY6Y],US>'D50 3D\D<8%>A1DW'4=9/FT,V"28W)BAO$
M:0' R.*LRQ7XA>65HU4'#,."!]:?_8HCUEIK8[;8?=+'))QS6G)%&\30RDLI
MY/.,UJVKW,E%WU,[P_JOANRN+@:SH\]]NP(S'+MV^_2O4/ ?B7PII$UU/;Z?
M<:>I7(,LFXR'T KS^VMK:-\06P+=RJY/YUK0:3?70#^2(T )S(<  ?6LIM25
MD:Q@[:GI%]\6+50PL+!Y&' :5L#ZXKDM0^)GB26[5X9XH(R"0@7-<?<2XU&"
M"U9KF,N!-,B':O., ^M=A<:%IL<,9,3-D'+%N>E3R*.K&H76A&_Q+UNX-N+F
M*VE:"0.I93DD5T4'QDGVJ)]'1F!P2LF/QKSSQ'IZV5I;2:?%(TKL XSG(]JT
M-/T/3M3L%NK>[E#  .A'*MW!':JY(;BY7>Q3U_4UUOQ+<ZMY6Q9<?NR<D8[Y
MKD[G3+J:[FE4*VXY'..*[1_#4@G>.*[4X/&X<XJ.;PW?1(Q$L3<9.#VIQ:CL
M$HRM8XN.SN8&+?9%=NQ)X!JU#::UJC?9TRD;'E2VU1[FNA.C:E&JDPAE;I@U
M7EM+V/)>!U [CT%7S)DJ+ZEVP^%=Y<%?MFI0*#@XAPQ'XUUL/A#PIX9B66\\
MF292#YEPX8D^RBN!@NYP@>!YQ$21N0G (]<4WS%DE#OO:0<Y<$X/XUG)2-(\
MJ=V>IVNN++ R:-I4]R >'P(HO\34;:9XCU-C]IU%+*$GF&T0DX]V)_6N&MO%
M.K6R!8+TJ@."FT8Q]*LMXUUN59 URFUXS&550  >XQT-<TJ4V]#J5:$5HCNK
M+PIIMM.QE O)<9+2DNWUQT%::7$4&M?V3!:?OOLYN&S@*JCMQ7#:=\1[FR\H
M+I]LQ6(1$@G<V#R2>YJ:+Q["?$DVK2V3KYEFUN$!Y!/?Z5*H2ZDSQ#MH="=1
MN]3\-+>R%(4G:2/RXQSM4D=34*V\,/Q%T2*) @"%SSGG;R:P;;Q7IR>%K;3C
MO6XC,A+A<C+'(_G5FS\0Z<_CC3KZ:_#010E6E9< ,5P!CZU2IM,SYW*.I#H;
M%_%/B-\G!N /J 379>#\"75#ZS 9^@K@_#5Y;_VOK;O.B>;<;HRYQN'J*[?P
M=/"5U ^='\USQ\PR1CL*F:?-<<+6%T%@?B-XD<D_):*/T-4_#C@_#F^;!&Z^
MDSD]<R56MM=M=-\?:Y:RY-U>1A(D49X .23Z5F^$-::_\.ZAI$<.([6Z+22Y
MR6)?H!5\LN6[,^7WKD6I?/X[UH] ME&/U%;OA$[/A[J+'@O=O^)SV_*L&_S_
M ,)GXB<CA+>)<=^HK,\!7,T][KD4LKM! "T2$_*I+<D#IFK:O$N:UL=7X*U&
MT@\/ZG9O,OVN>[<K"#EL<<D=A57P=XAALO%^KZ.('EN[NX# *0%10H!)/<US
M'@'YO&^MR@Y(B?!QT);K4_A$!OB_,1SC=D_@*3BE<5B;Q]@:-<@9).I'/O@5
MYY_:=YI=S!+9.(Y%  D ^89X./2N^\=D_P!E-C)!U!S^E><7H^>,'J64'VYK
M6BO=(J_$>_Z)"(]?MB6=V_LY6=Y#DL6//-9?Q4 _X1:%2,YN!@$^U;.D@_\
M"21KT TR(5A?%=L>'+<<Y-P,?@*YHZ3.C[!1L %^!QX."&P#VYIO@9-GPP\0
M2= 7P,?04^#CX&1<X)4\>^:D\%#'PIUEL9#2'\@!5ROJ879W6BX.A6/KY*Y_
M*J_BL'_A&KP8Y+*/U%7-- 32;/&,B).!Z8%5/%-Q;Q:-)%.K.)9  B'#<'.:
MS2U-DCGK88^(]RO]W3XESZ?**ZXH=JCN!GK7FVEZ^9/B1<K+'Y?FPK& W7
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M?FLJVGCDNB\(/EL. 1BM.8$6\ SC!)%3).Y:>EK%;4D!DC'WAY?/M[5S4T8
M)*@C)KIK\XF..,)DGU-8-P"551W()XZBKB[&<DGN8K0%U*H"3GI@G-3P:/>R
M@".SD/')V\5TR:O8:5:0W4MHYBD)$;@##$=>:W/#^KR>([2^FM+=(+>T4%R[
M<G/3%4Y22N1R0O:YYA<V<L%R8I(BK <CTIK0#/W3G'I6QK5L\NL3LK$$G/'-
M4QIET^-A9B3CI5J2M=F;AK9%#[.2O SCMBF-$1U!'MBM<:%JS@;(9&'^[UJ5
M?#&O$Y%E(P_W:.9/J')+L8H@_=8QSGGVJ,19DXX%;\GAO7HH9'>P<1JI9B1T
M ZFLR*-G(<  =,&FI$N+6Y19#\W'? )IIB((Q6TMC$%W.X /7)%-N;2)+0RJ
M"3NP#V-+G#D=KF.J,3C)';K3BKH1AVR?>K"("[9P,>E-E*E@#GCTJ[BL1AY\
M9$K\>YIPO+M -L\@Q_M&K 3<H*Y Z$XIRV0"DNX4 9Y[T)^0]>A7.HWV?^/B
M3\2:7[;<IR26R/XCG'TIA>$$@$L3[=Z&N%) (P , 8HMY"<GW-V[35M(L;.Z
MN8K<PW W18(8CZCM4">)[E#DP1DCV K):Y,BJK-(P7A022!^!H695."O4<TN
M5=@YG?1G16GB"[O9EC2W4D],$ 5MBRU:6+S"((P0."V<5S6D7EF+F(%MAZ9(
MXKN7(CT\'<HZ'.>",UE._1'3"S6I1C\/7,N&FU !<9(1 *F3PS9X!EN9W8]0
M#@5?68^4,#.5-31ONCC8] .:Q;?8V449]KH5B+M4*N0#@$N<@8K0:(6ZI CG
M;OP 3FEMB?[04#J32W;G[6AQP&Q^-+7J4DAP#PRR.>3N (]:@G+"X:; (51Q
M4UPS&1@1CYAGZU$Y)$V0< #%(H=M>4K,HRH!X-597E<$JF0#^%:-NP%D>.@J
M"-AY0Z8)H%82>4/9J >0N#D=ZA,@,"@ DA2#Z@U,H ' R":=9*K7T@!50%/+
MG /M3U#1$.]0(U) ^0U)9N#8R 8)P<9I/E>YQ@8"GM4(4 8 X*$\4M1ID41S
M 0"0"32H^8AU)'2E2(":+D %<X!ZTL\:I=(BC:#GBA6#499OE9R2!@U7&7BE
M).06P0*E"& .J# ;KGUJN(W4",9PQR?6GH2FTP-E;2Z5,C!$V.&7/3WQ3_!L
M5MY%XT97)FPH'7&:>NF1ZC83!RX:-_E(/ XY_"M;POHMM9:6LD:[G=N6)X//
M:I<THV;*4;RNC%US6+[3+MDM9=GFS$$GG  Z#/2J/]NZRXYU"0>P %'BEQ_:
MJ @D_:&R /0534,W*QN>O1:I*/*A<\N;0U;R^OO^$1AE:[F\U[S:7#$$C'2J
M*1O(NYYYY#GO(3FKMU#<2>$+.$0R&0WI8*5YQCK3H]-O^BVLO?M0[6N./,Y:
MFIX0MUCU:=BI)\H\DDFHO#2R+8:E]G_UOGOLR<<Y/4UI>&;"]M+^>6YMGC5H
MR 2.O%5/"&&@U'N!<,>?J:SOH[%M=SE+A-6N-8MP\)7;(0 2,%NYS6SX@1TO
MM.\TC?Y7.#[ULO82?VBMTP40 [@0>2Q[5D^+21?Z?C)(0@'\:TC*]D9N/*KG
M2:408A@#[HZT4S2VVQ#"G[HHK-EQM8Z/S&'':E\PCJ!53<<_>_6EWL?I7D<K
M/<Y"UYX((]LG/:FB[B(^66,COAQQ^M4[J0K8W)S_ ,LF_D:\1MHKR]DG$5PR
M[6R<L1GK75A\+[57;M8XL57]B[6N>XW>G6.HD-,I+8QN20 CWXKD?%]A;:#I
M4=W8&7SFDVDO)N&._&>M<,MAK0_U=TQ&.,2'_&FRV^IQ0XO)6DC8@*"^<'UK
MOI8?D?Q'G5:RDOAU*LDANB7E9%8DDC&,U$Q&XD!2#Q@$54>TFNK];>W5GD8X
M '.379>&/A?J6M1R37<WV*W5MN74[F(]!79-Q@KR9YT5*3T1R;,H.X*.,G-:
M$>7L(Y,8Y.?2M;Q=\/KKPN(I8[AKRVER ZJ00?0BLFR!72U1@1R>",&A2C)7
M3N6HR3LT9*WTPN0<C&['3M6H]CJ5PS-86]Q*@'S&-"0#Z<5J_P#".V\G@W^U
MRY5UEVA O7GUKTCX4OLT;4&R!^^&/0<=ZSJ5U"-TBXT6W;N>,64>HW6JPZ>-
MT=Q(XC =<$$^H-=3<> -<AE=!-;.5.#DXKNO%FBV<GQ T&\A,<%Q,<R@#AL'
M@UK:CY)N9'BE63<_)'(],9]:REB=$TMS:GAD[J3V/(/#MM+;>(;B";'F1J5;
M;R,BO1M%P=*../WK9'K7#:</^*IU-N1ACS^-=SH@_P")+&1R3(QS^-1B7[MS
M3#Q2DT:2?*#@_@/2N)^)#L?LBYR-H_G7<1A3&')(+$@ =\5P_C^*6XU;3[:-
M2TDNU47'4DUCA[\YO62Y2C9IM52#DA>N.!6I(,Q0[ACC/6J:02V[/#(I5XR5
M9>X(ZBKTI(6W & %'7O73+<Y([%/4A_I+8Y!7!Q63,NV13_=/&:U]2&+AR,]
M #6<5#2'=@\CJ/:KCK8B74R_$&KVLOA/2=*A8--!)))+CH,DX%=%\+<?V'X@
M!SRL8X^IKSPQ(]^XE9DB+G<P&<#->C_#>-8](\0(K';F,*2,$\GM71.RA8YJ
M:;G=G*:T;N7Q-+;VN]G=@J*@Y)(XKH;WP7XSTC1?M[J2D8W.B,&9!CJ0*N>$
MWM4^*X-UM[B//3=CBO;9BJ13/<$"%58REAQC'.?6N.K7=.48I;G1&G>[/F%/
M%NN08"7C8[<5.OQ \21\"^8?@*SM5,+ZS=-;<0M*Q3'IFC2=#OM>U!+'3H&F
MF8Y('0#U)["NM<MKLQE*5[(U)?'_ (AN8'MI;W='*"K @=#U%<].)/,"1AL8
MS@ DUKZ]X2U;PW>0QZC;A!(04<'(/MFNM^'5]9V_B-]-N;".XEN1B.1@#L(Y
MX%*4U&/-%7",93=F+\(_#5KJNIW=UJUMYR6Z#RXY <$D]>>M9?BB)5U#4$B"
M*JW!"H!@*/85ZYX@\1V7A'3OM(C@>0,%-O&0K$'J>*\5U36(=8OKD6L3;[B7
M>H/)&3T-<M*<ZL^:UD;2C&FN6YB1QD2$M@<\D]A5C2]-74-3,,OV@P@$EX(C
M(<XX&!ZFNUT[P9H-A;QZGXMUU(XC@BQMV!E;V..E6[OXLVNE6[6/@_0[>Q@Q
MM6XE&Z1NV37;8Y6^QR\/@OQ&;5KJXMQ8V8S^]O&$9(^AY)_"N<N<F9HA*LR*
M<!AG!^GM5W4];U;7)#+J=_-<G.<.W'T Z51V<9  /H#TIBN,1 ,C SGKBG=S
MW_"CD=>/2CMWH)0=L]AT&*:4R"1U]33B!D<TI^8@C@8_.F-ZD2*&<+D D@$]
M />N^TSX:^*=6CC:WN[5[9@"KBX#+],#H?K7!LN>PSV^E:^A^)]3\/'.GR^6
MX;+%B2K#T(S2>HXNSW.LOCJ7AEA8ZS8.(X@4%S"-R$^YJY8W]K=Q1M;7"R$#
M!4$ C\#5ZV^,<-Y#'9:UHL3V4BXN2A!)/<X-8'BK2_#=U$FJ>&=9MX$ S]C?
M*N">P-9."9T1JM%^.)8-LJEPS.23N)_3I3=SS0M+Y\@D#D#!' S7&6/B74;/
M;&[+/&"25?D_@:Z?0==T*[N;:+4YWMXRQ:8$': .0H(]:S=-IFBK1ZDSF9Y7
M_P!+G.7!.!G ]<#M6A?:9JEM'<7)E/V50H+.O+;NF,5V5D-'LEU6[TYK9;2X
M95#NP(52N2 3TYKG]2\00:[:-I&A03:A=L(UQ&I"+M)SD]*/9LE545HL_P!G
M,,Y)7C'K69<ZU8:9:!;F<";&3&O)/^%3ZAX3\7?96;4[JRT:T .=\G) [CN:
M\TU"*"&Z9(+IKK!YE*X!/MGG%5&BKZA*OI9&Y=>.)RI2RMQ'SP[<FL.YUF_N
MVW37$K$'C!('Z55VXZX)]:=CCK6RC%;(YW4D^IH6OB;5;4@),S #&'&>*VK/
MQJI(%W;E3C!=.@'TKD\8[Y%-QD]A2<4^@XU)(](MM9TZXEC:&XZ#'(.15J>\
MMSJ",)P1TY!%>:6@4W:+-<&W5C@R $@#U(KU?3_ >HW^CKJ.C^(++5W4 "W*
MX./3V/UK)T>J-HUWU*;$F1MQ.#TJ$G$R9/&,5'?SW6BWOD:SIL]C)C +*2I]
MP>E-CGBN9(W@E21.IP>?RK)P:-HS4CI/#B*994E&58D$'N#70K"D&(X(L0J,
M*O0#FN=T.4"9F&/O8)-=.DZGAF "@DDG 'XURSNW:QUQ:L<;JFHP:5XFF=K%
M;B2<JB C 4^O/K740V>MO&KQZ;9Q[L$ MV[9XKSKQCK-E!XD25)%G$;*Q"-Q
MD=LU2USXGZYJ2>3:L+.W P!&?F(]S6ZH2E%=#F=>$&ST77[]](T^-KJXL8[S
MS,+'N! '<\<BKFEP:UJ5NEQ#J&GE7&<)\Q%?/TTUS<2&6>1I')SEV))_.IK/
M4=1L)!):W,L)!R"KD?I6GU7W;)F2Q:OL?0\UEJ>GZ?>3W=['-((6,81<8('O
M7&^"[<OI;RN[%Y9&9CV))KE[3XHZY':26E\([R%T*EG&& (QD&MCP?XHT>"Q
MCM)KHPR$DY<<<GUK/V$H*VYK&O&;L===KMME&1MW#C%<IXM'_$PTX$9^0^V.
M:[*=X)X(S!+',"<@HP.:Y3Q@@&I:;UQL)QCWJ(73LS6>JT-K38QY6$S]T$YH
MJ73$P#SCY111<2N6=Y ]SP: [#.>??.!7!:1XMUV"U6:_P!-,MN#_KI!M./Q
MZTFJ?$W"F+2;)8SC!DD.3GV%1]2E>QT_VG!([B^E*:;<LQ508F W'&3CL*\H
MT0IYEUF1%;(.&[C/6J']K7^IZI&UU=22$MR"3@#T K.U(E;^7!P,G&.*[*.&
M4%9G!B,;[1J2.KOM1MM/"EG20L.!&0<?6J*:O)J:M&L*)'&,C YY]:J6FCV]
MSHDUVTK"9$)"]N*9H2?N;EL^@K14XI&$JLY/4N>''6+QM8DD\3+G'K7T-;7T
M.YH7F&X,3SP/RKYEAU"72M<CO8=K20N&4,,@UZ-IOQ&TZ^;9?PFTE<?,Z\J2
M>ON*YL91E42<37"U8QNI'J=^R.BH5213D\@$?@#7B7B-U.KW*A54+G&!@#\!
M7KEE*EQ9Q-;S)-"RDJ48$UX[KOS:K?-SD$BN?"*4969T8FW)="0ZHS^ ELG/
M6XPI]>:=IWC"Y\.+):I$DD+MN9"2"3C@\5@VUS%)86MJ"WG+,6VD<$&JVM#.
MHL!TP *]'V<6[,XG5DE=%U_%%^^I_;VE+S#(3<<A ?05TB>+YM#T'3X[:2.8
MN2\Z2#+$GGKUK@#'LC8'J""#43.SD9)Z8YJW1BTC-8B<;^9W7AZX^VZG=W14
M*9\M@'H<YKL++6;#3M)MXI9F:0.Q,:#)'/?TKC?!B?>8G "C(K(U?4I1>7$*
MY50Y&4XR/<USSI<[L=-.JXKF9ZM/X@MH+615=$8(&C ^8C)QD]JX:RO;K4O&
MFEBZN&F=;U0@;J #Z56>>X?2[**.)L?9E)*J>@8DY-<[87<T&O)=6\C++'(6
M1QR0><4Z5%1;85J[:5NIZ-=G?J=\<DYN')_/UJ24']P0,@@54LBTT3R2$LS-
MN8D=2>IK0?/F0=,8&*B6Y4=KE#4<?:9!G@@9%9T@ E)&>#T_"M6]3,]QW;C'
MY5F2 ^;O )'<#J>*<2))O0B\->"[C6;&YU7[5"(()3YD;-V![_7M6UX&V_8O
M$6WA3(@4>@YQ572H'L?#WF+*#%=AUE5 3@YR,XZ'BI/ !8:9K@;KYJ _K5-M
MIE<BA9G&:U+)%XDN)8V99$?*L#@@CO6C?>./$FIZ<+6ZU)VM\;2J@ L/<CFL
MC7R!XAO/]^L]"2P!SQSBM>5-*YS.;3:'-D8)SGMCM7JGP4N+9-1U*!BBW,D:
MF,DX) )R!7E#/N<MGCH*NZ-(R:M;%'=26ZJ2"/RI5(<T&A4Y6DCVGXOW=K'X
M;M[1BANGF!B7() '4^PKQR ZFNLA[)7CN40D&,9( ')KJ-4MTEMYKBX5I;@
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MO6O8U2*V@M,,"7BSDCT-9>MV4EU-"B''H3SDTX-*T68U7]I%>'5(55BQP">
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MV;#G@<"H8640<D<'I3X)/]%)P0"#DUEW%X(+8EN/IWK!)MZ&\I)(T?-14R&
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M"W^4-G ^:L.R"I=(S,  >2>U=#I%K)JUPUO:,CS<MAC@$?6LYJVQK"3;U+L
M5I%#-@;AECV%:DLMM)$L-LT<;A@29S@D^H/I20>%M5251(D)&[G]X.!]*FU+
M1KV2)FALE9\;4.X8!'4_2N.6LM!UHS:LD16TJ7!NI;C8 @ PB[3D=QZUGQ7
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M8)<J/,J-\XIE<G&XGMR:>YFB52P=5894G(R/:O6_#O@'2].>PO[YUO1=6QF
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M5QD*I...^*=J)(M88SE6\Q<@C!Q]*\UN1Z7) N)/<D+#)=3R1X!"22$@8X&
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M24MPDTA1P, 8)J@/"&HO]Z2) >..:M)X*5%S+?H">N!R*32;'&4KFU'=V,K
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M0ZK1P#J"[[N(#!P3( ![UT1>T1C(^I6P8C!/FC)'X5YGRB@K@#W'-*8S*-V
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M*P(*%1ZXJZR84XD3W*GFJ(9A)]\D$XYYH;$*H@4E3(>/4458:,G^Z?\ @-%
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MO"8)H5VGD#"'/J34<CQ2*-K,<>@J$1OD @J/8]J.HU<V=-T(:G?^0OE"0J7
M)XP*OZGX9FT6P:_<PNB,%(0DG). :R=%_<ZW9LLCJ3*H."1D$\BNS\6PM=ZQ
MI-BLA5;B5@5R<$9'45W4*,)TF^IY>(Q-2G745L<UI.AZMK*-+"B0VY.!+(,
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M=2,]NU=*PE+E2L<3Q]:\G?9['/V&E3:I.;=&2-XU+-D@'K@BM!_!5\1B.>,
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M]6@ZSB_:;FG%I/B/0+K?9F0Y;.$&Y6SZCM75Z_']L\(R&_A6.;8K;1_!(<<
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M"P/8YHN#L5EMP!_K$'L#15?: 3P>OI118"#S9"21"1CUH,I!Q+&>>F17<_\
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M4$TYQA2*5V!4)'/I4? '(%2,/>J[=*!,=P<C _*FD#':F]3Q4F.!5)DZC,#
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M_P#&,4%G;Z-JK!(U 6WF/0#^ZQ[?6N*FND-O,%(1BI.YCDD>F!4UA:?;=*5
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MP.N.](HIC0]-56 L(0IQGY*GAM8;2(K;0I"O0A% S[GUK&T[6+[4U'V;4HB
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M^E-)B<D2W'C%[F*2UL=)B@BD&TLQ+, >IP.*C\.K<:3KT>IPRAX<EI87;!8
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M.>:LF4 Y8KC'0'I5. M+*V54!1P<DYP>IJSD!2"1P/2J>PEN,,X=0LB!E!R
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MW5B3S$Y^>/W4]_I5J2>A+N?44D1!P5 ]>:J/$P/*BN)\._$$3:=_HC1WT>X
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MOM4O[:RNY(&O=/M/W>5$LH5\DCG!.<$9KB?'>H17'A.YB&I65P=ZE8X9E9@
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M+C'&.>/RK.>Y<?0T+_4KZ76C-<O%-*H.4F7((SDD9Y -<U)*I\5Q2HJKOW$
M#Y1GL!Z5KZZ]R"+MT+-L!!1N3GMQ7,0W32ZO:3EB" 3SU%3'5A)]&69-LFHW
M&(G1TB(8$8!.1TKL/"L#SB]N@2Q>8H4!P!C&"!7*WNHW$]]<>9('4*P4@#IQ
MQFMOPW=SQ120V81KEYI&(D.%*C& />K6Y#21V$ENK,HGMUVL3R5QDU4FN+*W
MD^S")HR "2"0#D_E3#JFHSSI:M91F4*6"H_4=R,GM6W82+=P+%-&D;AMIBD
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M%>79O=5NKME"--(9"H.0N3T%:UZD9+0X<JP57#S;FBLB;Y7QP1T-2PRF0D9
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MY'@_25(P1;+Q7E>J?#/498R]NL*R@< S AO;Z^]:OAWXH)I6G0:-JVG2B[M
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M#\J^G?(C.6VQD@\D(/\ #BG*=I(!!(Z%NN*?L$#SJMT1\P"UU @!4D((R/\
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M00  <J@ 'Z4;\$G&0?0\4HZ$@$9].:W45T,^9]6+B,'/EDMZ]<TTRR#J-H[
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M7FO_  L'Q3_T%I,_[H.?TII\?^)SUU:7\A6BI0,W7FSU]/!UN"K3WA;')PH
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M"K(YSN/<CV[4TA%R ;5^Z<L220,58ZCG'O2 A  7YSQGO3N.U('880/444N
M:* LCXABC< *LO"G."."/K4S^<T,RM&&+KD8JO  0&64J3Q@\BK49G1U(57V
M\,!P2*]2%FFB+M,P^^",<T=:EN%*7#AE*G).#VJ.O,FK2:-%KJ&:3\*6D[U
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M:P5HE$,+/OC4 *H& !T&.@K+MT\SQ+-,K,(;>$1,#R0S')P1P..M= @1!A
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MJ&HZ39M]KMH9/*$BH<DD$9'TKF]0MY[.62TNT,<\3!67L?<>U'([$V9U?@0
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M6"G:0.]:;6CW>J0M+-NG-EYP<#!!)X /8"LKQ/XKGT*1%:5KC4 N(8RQ90,
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MTJ1N^2B%L#)P,X'O6M)83Z0[+<&%#*&3#C<1@X/'4&JPC2UF*BXD>,@!WB!
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M#A2P))]@3_A6C8ZC$N(93C.%&3TXR3^HK2W5&$9)Z,Q0A2&->[K&#ZDLY/\
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MD^>QY'3IZ5Z%>7":EJ^ISV[QS(S1J'Z@A5Z@_C7-7:+ 3)(T:Q[@"2<#.?\
M"B,Y'3]3A)J^ESFI/&FJCY6T%N5*C<['@G)'T)IC>+=;.6.B1XR&.YF))'0]
M>HK?U4P$^9;H\; @@J^5(([>U9AO#<Q%DM)F6-@C2#& 3TR>V:Z%"\;W/262
MT+*\K&3/XGUTQ KID$0).#DD@GKW[TW^W=?3"-86881@C((.T]NO3VK<NX7M
MIDMD9I9&VEBA#"/..OK6K)I.AOI=]<79BCO-WE02RR$ L0,# KCJ591=DR)Y
M33C'F3NCD1J?B*?D6EEAA@'R\Y [>]*\GBEXBQMK,*PR<P#@#OR*Z_6;2S\)
MS:'<VC3()XV^TF$[@0 ,[<].:[72-).K6*RB348K>6+*R32J RGT'4"H]O):
M')+"44SQV"R\5WD"SHUB@8@*2B@L"<=".G2O34M+ZQ^%5M>"QT^34XP?.$\2
ME6 8C P.M;-UX:;3]+$ M9+Z)B8BZL"R@C((QV! JQK#VI\!P7+P2"&$B5XM
MV"&4]#Z\CI6BG)K4R=*$7H<+<ZGK=EJ$-C/#IEFS*'(MX4/7&  1UJYO\3FZ
MDAMYW)C WD0HN,C/8>E6M>\.:9XDO+:^;5;&&X-LC+'), RMUYQ^52Z9X*TN
M.&275/$KM)*<LMO-PO&!DYYQ6L)16K.F%91?PF#_ ,)/J<!9)]4F4J2-@<*2
M1Z<58'BF4 ^9=W;''4RD8..V*YSQ;X/M-)@N+JP\0V>HP@9,4A E4'T]:N:C
MI5E::3H\&H6D\IG@"J(I N9"<XR?;UJ*E:VQVT\5"46G!'N.G&*[TJUFVJPE
MB!8$ [CCJ<]:\TA^'^C^(=+FOP)+2]2YE0R0L<, 3P5Z'K7H_AZW6TT#3H$B
M:-5C ".V2O'0GO6)X18)IFHQGI'J$H(].<_UJX2;5SRV[R=CQWQ3X"U7PGH]
MQK5OJN^TD !<##G)Q@CMSZ5Q%G<ZI>17%S%*H2 #>H4;CNXX&,D^IKZ'\8P#
M4OA9?PLZJT2F0,_3*L2/Q/2O'/#UM8C3KG4WM3NME/F8?YF![@>U9S:;'R2D
M^Q0\(:_::3KJ2>(+5;RR$9C,;@' !XP!7M>AZUINM13#0/"TL,,J@222Q>6C
M#MDD\_A7'^%[_P (R:S$MMH4,=Y+"94FU"0;3CN.V37;W/B+5TAQ9BPE);:@
MB8D XZ8'H/2LY.R'&C=V;-F]T9;J)BT-I).8PH$L8*Y X!)["N)U?1-=M1;7
M<^GJHC8Q,MN=P"'H?89Q5N3Q?J(U%+?[39[3&3)A22I'7/M6M:W_ (EN;<7,
M5]IL<."Q+@G*#^+CH/K0I-:LTEADEHSA-;FA)6*_NF@M#&LDG(!W!@ ,'D_A
M7KFDW>EP1VS-<P2M(@6.21E,BJ1DJ3UP..M<?</!KC20WVI:%<%022T1.![&
MN/D\(>'FNR;KQ-:0 -EH[4DY7ZGH:IM+452+DE$YKQII,%IXMU"%%@:W6X++
MAAMP>3C%8[1:>$ $$603@@<8KUO2;/X?6LDD-L(9Y%&7DN,R9'7.:L)K7@BX
MG,%BMG+(JEB([?) ')[<]*.=,JG&E%>\KLR_!$"W&A0D7:VL42D=0=V3R #T
MJ_>Z8(EM[@:M I>*51&5SC&""/<YXJSI<L'B)?)MC8P:9.I$<Q4*Y[GY1TY&
M*D7681/)X>6V(FT^)V61@"LD8&2RGMU[TE%[HXZC3G=:&7?SS6X!2_>Z$2@2
M"-2!&,=#QC-)IMXTFI+$K3>4ZA@)"<X/<U?GN+6YA$$UDTRA@<0MM\P=3DCT
MS6W(UA]FF6#2)89#$H$SR@@*#@$=S64:;4KMD2;M8\?UA2^IWF,<,3C\Z[7P
ME>P6'@JVGN8))K<$K(D<9<D$GJ/3UKCM4!&L7@/!)]*[WP."?#,*+P61T'/<
MY 'ZUW+X3);&1J%UX4\77MN'LKAC$AV3!#&J*N206'  &>*N>$[3P7/+,='L
M0]W'\YDN4+';SRI/''J*HS^'?$-MX(30X+:,7,EPYE EP!&3D 'U)ZT6?A#7
MM(_LR>UE%W$JM#<PJ OE*^=V"?O<DX^E0]P\F7IO&>@1W;VA,E\RY#1PP&0<
M'G Q@@5:U?Q#X:LEM_,MX1+<1K(D"VBF0 ] 0!P?:N:T#0/$GA+5YGM--CU"
M%U,?R2!6*YX//(/K5W4=&UZ#QA%XF32O/,JAI;5907B)&" 3P?J*2T"QN:!X
MBT+4-42TMD6VO@IVQ20"-R.I P/3G%><^-DV^+-0X(RX(_(5UEKHFM:OXZM-
M:NK$:?;08X>4,[  XZ=2:YOQZ/\ BK+P<#.TX_"NC#/WAP6I#I=EKLNG79TR
MU>6VG41W.Q0<@<XYZ55\_5K]8- B5GC63*6X4!MPZ\]>YKI]"OY['P7>W%K*
M8Y(KN(9!Z@D C\1Q5G5XXH/BIILJ  SQAG QUP1S6_,[LMO4R9XO%.F26>H2
MP/%%8QF*.3"D1@]C^.*HW.I>(_$ZR6K9NX8")6"(HVXXR2.:T/%NJWZ^(+RQ
M^UR?8V8!H205(P"/UK3\%)%:VEU=2X NKI85)[@#&/UIIV5P;25SB[71-1U"
M-IK*REN(T^5B@!P>W%,N=%U6PMFFNK">&$8!=Q@ GI73:?<7NC^.5TN&=XK:
M2[(DC'1@3D?I5/QQJ]__ &U>:8UTQL@RD18&!@9Z]>M-3DW9!=W$\%DB^N01
M_P L!T]FKU&$YTR$_P"R*\N\('&K3+G@P'K]17I\,BII$3NP50,$D\=:YZND
MC*9:XW\\#91D8&2!^[S6;/JD8D*PJ7(CP'!^7/U[U4^TS3*#.3C;@A3@?EWK
MGE-(2@V:TM_#$[*K;V! PO/;KFKVB 7MRXNHR(P 0J,020.Y';VKGH<9 1!@
M]>.M3KXOMM"D-K;[)[^7(5,_*F!DECZ #)^E9.;>QHH6.IDT#PQHTIUFXA6&
M123YSR,6)(P0 3R>V/I6!;^([6^U.Z-M +*!2 XF)$LIQP0#T '/K7!Z=K.J
M:_K<^MZEJ5HNGVKF.)[H-L+,#M(4 D ]CZ"MJ%Q>ZI'<KK6BS7(B4!4616W
M<D\<CV/6B['9/<ZR+5;;S2[SJ%*8)!XR#_/%<]+XGTAKY=MRQ/FS1XP2I#)@
M=.,YK8L=.O\ Q#I]Q=&73D0@QE5C("CU&!7%7G@+4]"EM_)":C%)<CRA$"!D
M@Y#"A35]1<NNA:\)ZG8:%HEW:75JMQ)$ZN0 &&Y@3D9Z<8S56;Q3<>(K.\M'
ML8H(HU^5HQC<N2 "1C(XXJA/974!UJT;38Q,4CPJM\T9 S@$U%I=I=NCDA%:
M6,AQ(Q'ED>@'7\*.=#Y3H_"?B6+2+&&TN%Q%/,P#XX4XXYZ8-7M3\:6IOD7[
M%?/Y2RQL$B)!#+P1CJ*X@1-):PQ37,< !8B,J2"2>OMTJA.^H)=Q& CS%;RU
M</@,"#[^E5S(EQZG6P^/])BN(99H;L>78"$*4(^<'.1['UK;T'XE:?>V4:7;
M-'=I$6( (&1V'?.,5Q>D0W4]Q;BR%O<R26T@$MTNY2%;!7:<X(Y'O6G!8P+\
M'[Z\N[2(7*B2&":*$$D@DY)ZCG/X8H<U8.4ZBY^).CVTIAN8;R"0=I(RI_7C
M\J*P-'EEO=#TP?Z'/Y=LHQ=6Y?' [FBE[0.5GE5MJ2G1;B*;)B>4&0DY+$#
M ';ZU5T]K$W<,4J*5=OE=B1M.>,^HK+FF,@ P%5>%4?UI@!8' SCJ:=C95&=
MU?BVT>T>^6WC%Y*Q5?);$:C&, 'DY%6-#NK:^TF2_P!0!@M[-B$$( :64C@
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MDKFZU)/,Y(P/R%*9,#T)'4$U7#_-UZTZ1Q@ >E-15@+"S< #KZYY_.DFE:=
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MT^I&>*2;(ERVT,SSF!RC,..23G-,:=^AP>#DD5>'V64D@+D]LXJ*6R3:2C,
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M@;0.F:Y4M3D]J=,=1@F7*S*_/?@BHG82_?B0CU(KF'?G: 23W%/2ZG@P?.(
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MO^-.*LC>I.$M3P%8W/WG"CVXH\M8SGE\CGGI7O)_9RM&&#XBN,?]<%_QIO\
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5BO4C\(83_P QB;_OTM%/F0<K/__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
